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INTRODUCTION 
The term "mycoplasmas" is used as the trivial name for ail members of the class 
Mollicutes. The class Mollicutes is composed of six genera which include: Mycoplasma, 
Ureaplasma, Spiroplasma, Acholeplasma, Anaeroplasma, and Asteroleplasma (186). The 
members of this class are cell'wall-less eubacteria that possess the smallest genome size 
thought necessary for autonomous existence (184). As a result of their small genome size, 
mycoplasmas have limited biosynthetic pathways. Generally, the macromolecules required for 
growth must be scavenged from the environment because mycoplasmas possess only catabolic 
and conversion pathways to obtain amino acids and nucleotides (reviewed in 62,63). Thus, 
complex undefined media are required for their growth. Despite an apparent fragile existence, 
mycoplasmas have been shown to colonize humans, animals, plants, and insects (reviewed in 
185). 
Mycoplasmas have become recognized as important human and agricultural pathogens. 
They are generally mucosal pathogens in animals, colonizing the urogenital and respiratory 
tracts (222). The human pathogen Mycoplasma pneumoniae, which causes tracheobronchitis 
and primary atypical pneumonia, is the leading cause of pneumonia in older children and young 
adults (111). Ureaplasma urealyticum is a cause of nongonococcal urethritis in men and is 
often associated with pelvic inflammatory disease in women (111). Recently, a strain of 
Mycoplasma fermentans, Mycoplasma incognitus, has been associated with AIDS (reviewed in 
125). In addition, mycoplasmas have had a great impact on both the agronomy and livestock 
industries (reviewed in 120, 222). 
Mycoplasmas are thought to be a product of degenerative evolution from Gram positive 
bacteria (135). Like many Gram positive bacterial species, mycoplasmas are A + T-rich (60 -
77 %) organisms (186). Because of the phylogenetic relationship between mycoplasmas and 
Gram positive bacteria and their lack of a cell wall, they have been compared to Gram positive 
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bacterial protoplasts. Consequently, the basis for the development of gene transfer methods 
and tools (i. e., transposons and plasmids) in mycoplasmas has been derived from Gram 
positive bacterial systems. Gene transfer via conjugation, transfection, and transformation have 
been demonstrated in mycoplasmas (reviewed in 51, 52). 
The use of Escherichia coli cloning hosts has generated misleading results in studies of the 
regulation of both mycoplasma transcription and translation. Gafny et al. showed that both E. 
coli and Mycoplasma capricolwn RNA polymerase recognized the M. capricolum rRNA gene 
promoter, but during amino acid starvation, transcription was activated in E. coli instead of 
repressed (67). Notamicola et al. have shown that E. coli initiated translation at internal sites in 
a Mycoplasma hyorhinis lipoprotein gene (170). In addition, most mycoplasmas, except for 
Acholeplasma, have an alternative codon usage in which the UGA codon encodes tryptophan 
(94, 265). The alternative codon usage results in the expression of a truncated mycoplasma 
gene product that may or may not be detectable (101). Therefore, it is important to be able to 
examine mycoplasma genes and their regulatory elements in their normal genetic background, 
the mycoplasma. 
The lack of genetic tools has made the development of mycoplasma cloning systems 
difficult. Only two transposons, Tn9/6 and Tn400I, have been shown to be useful for 
studying mycoplasma genetics (53, 54,133). Broad host-range Gram positive plasmids have 
been examined as possible cloning vectors, but they have proven to be unstable. Naturally 
occurring mycoplasma plasmids have been examined as possible cloning vectors, but they have 
not been shown to maintain and express a cloned gene (reviewed in 52). A cloning system has 
been developed in spiroplasmas that uses a spiroplasma virus as a cloning vector, but, the virus 
has a limited host range (231,232). Mahairas and Minion have developed a cloning system 
based on the ability to integrate cloned genes into mycoplasma chromosomes via homologous 
recombination (132, 134). The stability and versatility of the integrated plasmid cloning system 
3 
make it possible to incorporate any DNA sequence into the host including cloning vectors 
designed to study gene regulation. 
Therefore, the goals of this study were to expand the mycoplasma cloning system 
developed by Mahairas and Minion to include a reporter gene for the detection of mycoplasma 
upstream gene regulatory elements. The approach involved the development of both plasmid-
and transposon-based reporter gene vectors. Once mycoplasmal promoter sequences were 
identified, the sequences were analyzed, and a consensus promoter sequence was be derived. 
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LITERATURE REVIEW 
General Background and Classification of Mycoplasmas 
History of mycoplasmas 
Mycoplasmas were originally isolated in 1898 by Nocard and Roux (169) as an agent of 
bovine pleuropneumonia. As a result, during the first half of this century, similar organisms 
were known as "pleuropneumonia-like organisms" or "PPLOs" (85). Despite nearly one 
hundred years of study with these organisms, their growth requirements and genetics remain 
an enigma. In addition, their taxonomic classification has been one of the most confusing and 
controversial battles encountered for any bacterial group. 
Prior to the 1930's, mycoplasmas were considered to be viruses because they could pass 
through filters that blocked the passage of other bacteria. As the true nature of viruses became 
apparent, however, it was obvious that mycoplasmas could not be considered to be viruses. 
Interestingly, the mycoplasma species recently identified in AIDS patients was originally 
thought to be a novel virus (126, 127). 
The most difficult battle for independent taxonomic status for mycoplasmas was the 
distinction between L-forms of other bacteria and mycoplasmas. Following the observation that 
bacteria could be induced to grow as stable L-forms (118), the notion that mycoplasmas were 
merely L-forms of other bacteria predominated. The isolation of walled bacteria in mycoplasma 
cultures enhanced this notion (181). Following nearly 30 years of heated debate, the 
controversy was resolved based on genomic analysis of G + C content (181). The A + T-rich 
mycoplasmas could be definitively differentiated from the G + C-rich bacterial contaminants. 
Just as the establishment of taxonomic status for mycoplasmas was highly controversial, 
the appropriate placement of mycoplasmas in the bacterial phylogenetic tree also was a subject 
for heated debate. One model proposed by Neimark suggested that the different mycoplasmas 
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arose from different branches of the bacterial phylogenetic tree through degenerative evolution 
(167, 168). For example, the model predicted that the genus Mycoplasma arose from one 
species of bacteria while the genus Acholeplasma arose from another. The other model, 
proposed by Morowitz and Wallace (155, 255), predicted that mycoplasmas were the first 
bacteria. Neither of these models, however, are accepted today. The present model suggests 
that mycoplasmas arose through degenerative evolution from Gram positive bacteria (probably 
Lactobacillus spp.) and that the entire class of Mollicutes have a common origin (135, 136). 
This model was supported by 16S rRNA gene sequence homology studies (257). The 
Mollicutes phylogenetic order, from earliest to latest branch, was predicted to be 
Asteroleplasma, Anaeroplasma, Acholeplasma, Spiroplasma, Mycoplasma, and Ureaplasma 
(257). Thus, the association of mycoplasmas with L-forms is not entirely unjustified because 
they are thought to be a product of degenerative evolution from Gram positive bacteria (135). 
Dujardin-Beaumetz was the first to cultivate a mycoplasma on solid medium (cited in ref. 
85). He described the distinctive "fried-egg" colony morphology that has become the trademark 
of mycoplasmas. The fried-egg colony appearance is achieved by the production of a dark 
center that penetrates into the medium and is surrounded by a thinning periphery. 
The first isolation of a mycoplasma from a human source was reported in 1937 by Dienes 
and Edsall (44). It was not until 1962, however, that etiological proof for the involvement of a 
mycoplasma in human disease was provided (26). This organism is presently known as 
Mycoplasma pneumoniae, the etiologic agent of primary atypical pneumonia. In addition to 
being human pathogens, mycoplasmas have become known as important agricultural 
pathogens, severely affecting the agronomy and livestock industries. 
In 1936, another mycoplasma was isolated from sewage and was thought to be a 
saprophyte (117). A similar organism was later isolated from the bovine genital tract (57). 
These two organisms, unlike the pleuropneumonia causing agents, did not require sterols for 
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growth. Because they lacked a cell wall, they were later assigned a separate genus within the 
class MoUicutes called Acholeplasma (59). 
Organisms which produced tiny colonies (7 to 15 |im in diameter) were first isolated from 
men with primary and recurrent nongonococcal urethritis by Shepard in 1954 (218). As a result 
of their tiny colony morphology, they were originally referred to as T-strains and were later 
named Ureaplasma urealyticum (219). To definitively prove that Ureaplasma urealyticum was 
an etiological agent in nongonococcal urethritis, Taylor-Robinson infected himself (244). 
Spiroplasmas were first observed in 1961 when they were mistaken for spirochetes (177). 
Although they were observed throughout the decade as infectious agents of insects and plants, 
they were not defined as a Mollicute until 1973 (211, 259). 
The first strictly anaerobic mycoplasma was reported in 1966 by Hungate (91). This 
organism was characterized by Robinson (199) and was originally assigned the name 
Acholeplasma bactoclasticwn. Because this organism required sterols for its growth, it was 
assigned a separate genus for strictly anaerobic mycoplasmas, Anaeroplasma (200,201). 
Taxonomy of mycoplasmas 
The current classification system of mycoplasmas is an expansion of the classification 
system originally presented by Edward and Freundt in 1956 (58). The name "mycoplasma" 
was derived from the Greek word mykes meaning fungus and plasma for something molded or 
formed to describe the fungus-like morphology of M. mycoides (185). MoUicutes is presently 
the only class in the division Tenericutes which is composed of wall-less bacteria (186). The 
name "mycoplasmas" is loosely used to describe any organism within the class MoUicutes 
despite the introduction of 5 new genera since mycoplasmas were first classified. 
The class MoUicutes consists of 3 orders, Mycoplasmatales, Acholeplasmatales, and 
Aneroplasmatales. Because this work did not involve species from the order Aneroplasmatales, 
this discussion will focus primarily on the other two orders. For the sake of completeness, 
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there is another group of organisms within the class Mollicutes, the mycoplasma-like 
organisms (MLOs), that have tentatively been placed there because they lack a cell wall. 
Because they have not been cultivated, their metabolic or other distinctive properties have not 
been defined (185). 
Mycoplasmatales. The order Mycoplasmatales is composed of facultative anaerobic 
sterol-requiring mollicutes that may or may not ferment glucose and hydrolyze arginine. The 
order has two families, Mycoplasmataceae and Spiroplasmataceae (186). 
The family Mycoplasmataceae is composed of two genera, Mycoplasma and Ureaplasma 
(186). Ninety-two of the 125 currently recognized species are members of the genus 
Mycoplasma (185). Members of this genus have a wide habitat including humans, animals, 
plants, and insects. The other genus within this family, Ureaplasma, possesses species that are 
pathogens of humans and animals, and are characterized by having the ability to hydrolyze urea 
to CO2 and NH3 (220). 
The family Spiroplasmataceae contains one genus, Spiroplasma. Arthropods and plants 
are the primary habitat for the eleven species within this genus. These organisms are 
characterized by helical filaments and their genome sizes are among the largest (1,350 to 2,575 
kb) of the Mollicutes (14,121). 
Acholeplasmatales. The order Acholeplasmatales is composed of mollicutes that are 
facultative anaerobes that do not require sterols for growth (186). The members of this order 
are the only mollicutes that are able to modulate membrane fluidity by carotenoid synthesis, 
selective incorporation and elongation of fatty acids, and de novo synthesis of fatty acids 
(183). In addition, these organisms can metabolize glucose, but they cannot hydrolyze arginine 
or urea (250). This order has one family, Acholeplasmataceae, which has one genus, 
Acholeplasma (186). Members of this genus are primarily found in animals, plants and insects 
(251). 
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Growth requirements of mycoplasmas 
The Mollicutes are among the most fastidious groups of bacteria, and their close 
association with their plant or animal host have led to dependence on their host for many of 
their macromolecule precursors (144). The ability to determine the specific nutrient 
requirements for a microorganism usually requires the use of defined growth media. 
Unfortunately, fully defined or semi-defined growth media have only been developed for a few 
Mollicute species including M. mycoides, M. gallisepticum, M. capricolum, A. laidlawii, and 
Spiroplasma spp. (24, 74,79, 119, 202, 204, 246). In addition, the ability to define the 
organic growth requirements is confounded by the interaction between metabolic pathways 
(144). For example, alanine was essential for growth of M. mycoides only in the absence of 
pyridoxal (202), and tyrosine and phenylalanine were not required by A. laidlawii when 
alanine was added to the medium (246). Also, nutritional antagonism has been demonstrated 
between alanine and glycine in M. mycoides (202). This type of antagonism is common among 
eubacteria (e. g., abundant glucose levels inhibiting the utilization of other sugars in the 
medium). Thus, the precise nutritional requirements for many of the mycoplasmas are not 
known at this time because of the lack of well-defined growth media. 
Generally, the organic elements required for mycoplasma growth must be scavenged from 
the environment Mycoplasmas must acquire many of their amino acids because they lack the 
pathways to synthesize them. For example, M. arthritidis was shown to catabolize arginine, 
glutamine, glutamic acid, aspartic acid, histidine, leucine, and threonine under aerobic 
conditions and tyrosine and tryptophan under anaerobic conditions (226). Fisher et al. has 
compiled a list of amino acid requirements of organisms known to grow on a defined or semi-
defined media (63). 
Mycoplasmas require nucleic acid precursors for growth because they lack the de novo 
pathways for their synthesis (150). Mycoplasmas are capable, however, of converting one 
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nucleotide to another. For example, M. mycoides subsp. mycoides was reported to be able to 
convert guanine to adenine (150, 166, reviewed in 62). 
Sterols and fatty acids are essential for growth for all mollicutes except Acholeplasma and 
Asteroleplasma species. However, sterols were shown to be incorporated into the membrane 
by A. laidlawii if provided in the medium (12). Sterols account for 20% of the mass of the total 
membrane lipids in mycoplasmas. Interestingly, a cholesterol-rich growth medium was shown 
to reduce the growth rate of M. capricolum (122). Fatty acids were reported to be required for 
phospholipid synthesis and their uptake by M. capricolum required ATP and a transport protein 
(35). M. mycoides apparentiy lacked the ability to alter the chain length of saturated or 
unsaturated fatty acids, thus both fatty acids were required in a defined medium (204). 
Ureaplasmas were shown to synthesize both saturated and unsaturated fatty acids (207). 
Exogenous phospholipids such as sphingomyelin and phosphatidylcholine could be 
incorporated directiy into the membranes of mycoplasmas and spiroplasmas (39, 209). For 
further background of lipid incorporation, biosynthesis, and metabolism see the reviews of 
McElhaney (142) and Smith (227). 
Glucose was originally used as an energy source in the preparation of defined media 
(202). A study examining ten different mycoplasmas and acholeplasmas suggested that 
mollicutes do not use the TCA pathway, but rather they appear to ferment glucose via the 
Embden-Meyerhof-Pamas pathway (31,43, 139). Glucose can be replaced by other sugars or 
pyruvate, but growth rates may be affected (145, 146). Studies suggested that all glucose-
fermenting mycoplasmas also ferment maltose, starch, and glycogen (186,205). Arginine 
hydrolysis via the arginine dihydrolase pathway has been shown to be utilized by some 
mycoplasmas as an energy source (61). There are no reports of mycoplasmas using lactose as 
an energy source. Thus, it does not appear that mycoplasmas possess the ability to breakdown 
lactose to glucose and galactose. This implies that lacZ could be an efi'ective reporter gene in 
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mycoplasmas. For a review of carbohydrate metabolism and energy utilization in mollicutes see 
Pollack (176). 
Mycoplasmas appear to require a large number of vitamins for their growth (202,204, 
205). The vast vitamin requirement was based on the large number of vitamins and coenzymes 
(6 to 8) used in preparation of the defined media for M. mycoides Y and A. laidlawii B (204). 
Studies performed with spiroplasmas showed that only nicotinic acid or riboflavin were 
required for growth (22). The best growth rates were achieved when both vitamins were 
present, but high concentrations of the vitamins appeared to reduce the growth rate (23). Thus, 
the vitamin requirements for Mollicute growth has not been precisely determined. It is apparent 
that macromolecules must be scavenged from the environment because they do not possess 
complete anabolic pathways to synthesize necessary macromolecules. Moreover, the metabolic 
pathways they do possess appear to be cataboUc or are involved in interconversion (182). 
Little work has been done on the inorganic requirements of the Mollicutes. The preparation 
of the defined media and semi-defined media for M. mycoides and A. laidlawii implied the 
requirement for P043-, Mg2+, K+, and Fe^+(204). The author suggested that other elements, 
namely metals, would be required but adequate amounts could be obtained as contaminants on 
glassware (204). Tryon and Baseman have shown that M. pneumoniae is able to bind human 
lactoferrin as a potential iron acquisition mechanism for mycoplasmas (249). It should be noted 
that high concentrations of metal ions (Zn^+, Mn2+, Co^+, and Fe^+) inhibited mycoplasmal 
growth (203) 
The temperature range for mycoplasma growth generally is from 7° to 40°C (144). The 
optimal temperature is usually indicative of the natural habitat in which the mycoplasma is 
found. Mycoplasmas will grow and survive over a narrow pH range (144). The optimal pH for 
most species of vertebrate origin is 7.4 with a range of 6.5 to 8.0 (205). The optimal 
temperature and atmospheric conditions for mycoplasma growth are discussed by Gardella and 
Del Giudice (69). 
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Genomic composition of mycoplasmas 
The genomes of mycoplasmas are small and have a low G + C content as compared to 
other bacteria (184). For nearly twenty years, the genome size served as one of the major 
taxonomic criterion for distinguishing the genera of the Class Mollicutes. Recent data from 
analysis of over 40 different mollicutes shows that the genomic sizes of the Mycoplasma and 
Ureaplasma species range from 500- to 1,300-kb, while the Spiroplasma and Acholeplasma 
species range from 1,350- to 2,600-kb (5, 8, 32, 115, 121, 124, 179, 198, 236, 258). 
Therefore, some of the genome sizes of Mycoplasmas and Ureaplasmas are similar to that of 
Acholeplasmas and Spiroplasmas. This makes distinguishing these species by genomic size a 
less reliable tool for taxonomic classification. 
The size of the genome is an indication of the number of genes it encodes. A genome of 5 
X 10^ Da (approx. 750-kb) has the potential to code for approximately 650 proteins of an 
average molecular mass of 4 x 10'^ Da if no intergenic spacer regions are present (153, 154). 
Twenty to thirty percent of the bacterial genome is usually composed of spacer regions. Thus, 
it would be predicted that a mycoplasma genome would encode about 500 proteins (100). 
Two-dimensional gel analysis of the M. capricolum genome revealed about 350 spots 
suggesting that this mycoplasma encodes at least 350 proteins (100). As a comparison, 
Escherichia coli is known to encode for more that 1,100 proteins with a genome size of 4,000-
kb (123). 
The mycoplasma genomes examined to date have one or two sets of rRNA opérons 
encoding the 23S, 16S, and 5S rRNAs (I, 73, 215, 216). This contrasts to the 10 rRNA 
opérons in each of their closest relatives Clostridium spp. (70) and Bacillus spp. (98) and the 7 
in E. coli (105). The M. capricolum genome possesses 30 genes that encode 29 tRNA species 
(14, 161), whereas E. coli possesses 78 genes for 45 tRNA species (109) and B. subtilis 
possesses at least 51 genes for 31 tRNA species (254). Therefore, it appears that the number of 
mycoplasma tRNA and rRNA species is considerably lower than in other eubacteria. 
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The G + C content for mycoplasmas range from 25 to 40 mol% (186). The G + C content 
of M. capricolum spacer regions are about 20 mol%, the protein genes are about 30 mol%, 
and the rRNA and tRNA genes are 46 to 54 mol% (163). The G + C content of the M. 
capricolum rRNA and tRNA is lower than the corresponding regions in other eubacteria (163). 
The low G + C content of mycoplasmas is hypothesized to be a product of A T-biased 
directional mutation pressure that was exerted on the entire genome (163, 238). As the 
mycoplasma evolved, selective pressure must have occurred on the entire genome to replace the 
G C pairs with A T pairs. Muto et al. (163) suggest that the spacers are functionally the least 
important regions of the genome, and mutations in those regions are selectively neutral 
resulting in a mutation rate higher than any other regions. The A T shift in the rRNA and tRNA 
genes is least pronounced because most of the transcripts serve a biological function. Protein 
genes are more variable than the RNA genes because of the redundancy of the genetic code. 
Based on two-dimensional protein analysis of the M. capricolum genome and the relatively 
low number of rRNA and tRNA genes, it appears as though the M. capricolum genome codes 
for about 400 genes (184). Morowitz (153) suggested that mycoplasmas have a limited number 
of genes that are required for growth and has discarded many unnecessary genes as it evolved. 
The basic elements for DNA replication (64), transcription of DNA to RNA (66), and 
translation of RNA into proteins (257) have been conserved in mycoplasmas. In addition, a 
number of DNA-related systems have also been maintained including DNA recombination and 
repair (56,114, 131, 134, 261), DNA restriction/modification (137), and heat shock proteins 
(37),implying the necessity of these functions. It has not been determined whether proof­
reading capability during DNA replication has been retained in mycoplasmas (136). Thus, it 
appears as though mycoplasmas possess the minimal genetic information necessary for life. 
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Gene Transfer in Mycoplasmas 
The ability to genetically manipulate mycoplasmas through gene transfer is fundamental if 
an understanding of the genetic regulation of mycoplasmas is to be obtained. Gene transfer via 
conjugation, transfection, and transformation have been demonstrated in mycoplasmas (for 
reviews see 51, 52). Transduction has not yet been described for mycoplasmas. Because of the 
phylogenetic relationship between mycoplasmas and Gram positive bacteria and their lack of a 
cell wall, they have been compared to Gram positive bacterial protoplasts. Thus, many of the 
methodologies and tools (i. e., transposons and plasmids) developed to transfer genes in 
mycoplasmas were originally derived from Gram positive bacterial systems. 
Mycoplasma conjugation 
The acquisition of the tetM gene in clinical isolates of M. hominis and U. urealyticum was 
thought to occur through a conjugation event involving Enterococcus faecalis as a donor in 
vivo (194, 195, 197). Further investigations suggested that the mechanism of conjugal transfer 
might involve the Gram positive transposon Tn9/<5 based on several observations. First, cell to 
cell contact was required for DNA transfer between Enterococcus faecalis and Mycoplasma 
hominis (196). Second, it was shown that the Gram positive conjugative transposon, Tn9/6, 
was transferred from E. faecalis to M. hominis and M. pulmonis at a frequency of 10"^ to 10"^ 
transconjugants per recipient colony forming unit (CFU) (50,196). Finally, tetM is the 
antibiotic resistance marker found on TnP/6 (71). Conjugal transfer of Tn9/6 using 
mycoplasmas as a donor has not yet been reported, however. Naglich and Andrews described 
comobilization of plasmids pC194 and pUBl 10 in the conjugal transfer of Tn9/6 from 
Bacillus subtilis to Bacillus thuringiensis subsp. israelensis (165). Thus, conjugative 
transposons may provide a means of introducing various antibiotic resistances or other genetic 
markers into mycoplasmas. 
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Another phenomenon of gene transfer in Mollicutes requiring cell-to-cell contact has been 
demonstrated in Acholeplasma and Spiroplasma (6,7, 131). Gene transfer between 
Acholeplasma was demonstrated using cells that possessed either the gentamicin resistance 
marker from Tn4001 or the tetracycline resistance marker from Tn9/<5. Broth or agar surface 
mating mixtures yielded colonies possessing both of the antibiotic resistance markers. 
Moreover, the antibiotic resistance markers were located at the same place on the chromosome 
in the transconjugants as in the parents (131). The mating phenomenon was DNase I 
insensitive (6,7,131) ruling out a role for natural transformation. The matings occurred in the 
absence of polyethylene glycol (PEG) which has been shown to be effective in promoting the 
fusion of Bacillus subtilis protoplasts (25) as well as in the transformation and transfecdon of 
mycoplasmas (54, 224). Triparental matings in mycoplasmas have not been observed (6). 
The mechanism of DNA transfer in the Acholeplasma and Spiroplasma mating systems is 
not clear. The mechanism resembles conjugation in that the transfer was not DNase-sensitive 
and required cell-to-cell contact similar to the clumping observed in pheromone-induced 
enterococcal mating (47,48). On the other hand, gene transfer resembled a protoplast fusion 
event because transposon markers in the progeny were in the same chromosomal locations as 
the parental strains and prolonged mating in non-selective media enhanced the frequency of 
colonies possessing both markers. Hopwood reported a similar phenomenon with Bacillus 
protoplast fusions in which single colonies harvested from non-selective regeneration media 
gave rise to multiple phenotypes (89). The generation of multiple phenotypes was suggested to 
be a result of interruption of recombination at different chromosomal locations during fusion. 
Thus, the long incubation time in non-selective media for the spiroplasma matings might allow 
for complete acquisition of both markers. 
Mahairas and Minion reported that mating did not occur with M. pulmonis, M. 
gallisepticum, and the A. laidlawii strain ATCC 14192, and that mating appeared to require the 
presence of a trypsin-sensidve membrane protein (131). Thus, it appears that this mating 
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phenomenon only occurs in a few members of the Mollicutes, S. citri and an Acholeplasma 
species. Because it is advantageous for an organism to be able to acquire useful genes from the 
environment, the limited evidence presented here might suggest that these two strains continue 
to possess a DNA acquisition mechanism that other mollicutes with smaller genomes have lost. 
Evidence to support this notion comes from the observation that low-frequency transformation 
of spiroplasmas occurs in the absence of PEG (33,212) suggesting the possible existence of a 
natural transformation system in some mycoplasma species. 
Transformation and transfection of mycoplasmas 
Initial attempts to transform mycoplasmas was based on the treatment of the cells with 
divalent cations (21,65) similar to the methods used in preparing E. coli competent cells (82, 
83). These attempts were not repeatable by another laboratory, however (196). The ability to 
effectively and repeatably transform mycoplasmas was based on the observation that PEG 
promoted the fusion of Gram positive protoplasts (25, 89). Because mycoplasmas resemble 
protoplasts, Sladek and Maniloff first utilized PEG-mediated transformation of Acholeplasma 
in transfection studies using a mycoplasma virus L2 (225). 
Transformation protocols have since been developed for introducing DNA into a number 
of Acholeplasma, Mycoplasma, and Spiroplasma species (reviewed in 52). The DNA 
introduced into mollicutes has been in the form of a virus, transposon, or plasmid with a 
frequency ranging from lO"^ to 10"^ transformants per colony forming unit. The DNA size also 
affected transformation frequency as Mahairas and Minion showed an inverse relationship with 
plasmid size (134). A similar observation was reported with the 39-kb dsDNA mycoplasma 
virus L3. While attempts to transfect/4. laidlawii with L3 using PEG were not successful, 
electroporation was effective (130). Thus, the inefficient transformation frequencies and 
plasmid size have become important considerations when conducting genetic studies in 
mycoplasmas. 
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The PEG concentration, stage of growth of the cell, and amount of DNA must be 
considered when introducing DNA into mycoplasmas. King and Dybvig have shown that 
transformation frequencies of Mycoplasma mycoides subsp. mycoides increased with higher 
PEG concentrations (53 
- 62% w/v) (103). On the other hand, Mahairas and Minion reported 
that transformation of Acholeplasma ISM 1499 was successful only at PEG concentrations of 
34 to 37% (w/v) with an optimal concentration of 35% (w/v) (134). King and Dybvig reported 
that optimal transformation occurred when M. mycoides subspecies mycoides was in the mid-
late logarithmic phase of growth (103), but Mahairas and Minion failed to observe a similar 
relationship v/ith Acholeplasma ISM 1499 (134). Transformation frequency significantly 
decreased after mid to late log growth phase suggesting that once mycoplasma cells have 
reached a certain stage of growth they are less likely to be transformed. Generally, 5 to 10 |j.g 
of homogeneous DNA were required per transformation (103, 134). The addition of yeast 
tRNA was shown to enhance transformation frequencies in acholeplasmas (54, 134) by acting 
as substrate for a potent surface nuclease (149) 
Electroporation has also been used to successfully introduce DNA into mycoplasmas. The 
efficiency of transformation using electroporation versus PEG varies between the species of 
mycoplasmas and the size of the DNA. Lorenz et al. showed a 10-fold decrease in the 
efficiency of transfection by electroporation of the 4.5-kb mycoplasma virus LI DNA 
compared to the PEG method. However, electroporation was the only means whereby the 
39.5-kb mycoplasma virus L3 DNA could be introduced into A. laidlawii (130). 
Transformation frequency of M. mycoides subsp. mycoides with plasmid pAM120 was 2 logs 
more efficient using PEG (103) as compared to electroporation (260). It should be noted that 
the electroporation conditions used (260) were markedly different than the conditions that have 
been successfully used with other mycoplasmas. Therefore, the transformation frequency 
could increase if other conditions were used. In addition to the mycoplasma species already 
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mentioned, electroporation has been used to transform M. pneumoniae (D. Krause, personal 
communication), M. gallisepticum (Minion, unpublished data), and S. citri. (231). 
Development of Cloning Systems for Mycoplasmas 
The development of a cloning system in mycoplasmas is essential if studies of their gene 
regulation are to be conducted. Although some mycoplasma genes have been cloned and 
expressed in E. coli (13,110,157), the majority of mycoplasma genes may not be expressed 
because of alternative codon usage (265). Moreover, gene regulatory signals differ between 
mycoplasmas and E. coli (67). Therefore, it is necessary to be able to study gene regulation in 
its natural setting, the mycoplasma cell. 
The lack of genetic tools has made the development of cloning systems difficult in 
mycoplasmas. Only two transposons, Tn9/(5 and Tn4001, have been shown to be useful for 
studying mycoplasma genetics (53, 54, 133). A number of broad host-range Gram positive 
plasmids have been examined as possible cloning vectors but they have proven to be unstable 
(49). Mycoplasma viruses have also been examined as possible cloning vectors (231), and 
preliminary studies show promise. Problems with low transformation frequencies and the 
requirement of high amounts of DNA which are inherent with the PEG transformation protocol 
have hindered development of an effective mycoplasma cloning system. 
Alternative codon usage in mycoplasmas 
Mycoplasma DNA is A + T-rich compared to the DNA of other bacteria. For example, the 
coding regions of M. capricolum have an A + T content of 75 mol% whereas the coding 
regions for E. coli are 51 mol% (162). The A + T content for the coding regions for M. 
pneumoniae, on the other hand, are only 60 mol% (93). Many of the tRNAs of M. capricolum 
have been purified and sequenced (3), and examination of the anticodon regions show an 
extremely high level (90%) of A or U in the third position (162, 172). Muto and Osawa have 
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examined the nucleotide usage in all three positions in the codons of M. capricolum as well as 
their use in other bacteria (163). They found that mycoplasmas were A + U biased in all three 
positions of the codon. The bias was highest in the third position, followed by the first 
position. The second position was the most invariable because changes at that position would 
cause a change in the amino acid. M. capricolum possesses only 29 different tRNA genes (2, 
162,264) for the 62 possible codon combinations. It has been predicted that there are limited 
number of tRNA genes found in M. mycoides (214). Samuelsson et al. (214) hypothesized 
that mycoplasmas have eliminated a number of the tRNA genes by taking advantage of the 
"wobble hypothesis" proposed by Crick (34). Thus, the tRNA in some instances needs only to 
recognize the first two nucleotides in the codon, and tRNAs that would recognize the other 
three possible codons would not be necessary. Examination of the tRNA species produced in 
M. capricolum support this notion in that one tRNA species appears to be available for the 
codons that have the same nucleotides in the first two positions and code for the same amino 
acid (160). 
The most notable feature of the codon usage of most mycoplasmas is the deviation from 
the universal genetic code from a stop codon to a tryptophan encoded codon (i. e., UGA ) 
(265), Based on a survey of 6,814 codons used in genes in M. capricolum, the UGA codon 
for tryptophan was used 42 times, the UGG codon for tryptophan was used 7 times, and the 
CGG codon for tryptophan was not used (160). Because the UGA codon was preferentially 
used, a protein possessing a tryptophan would probably include the UGA codon. 
In addition to M. capricolum, other Mycoplasma species have been shown to use the UGA 
codon for tryptophan including M. arginini (110), M. gallisepticum (94, 96), M. genitalium 
(94), M. hyopneumoniae (107), M. hyorhinis (46), and M. pneumoniae (93, 94, 129). Other 
Mollicutes that have been reported to use the UGA codon for tryptophan include Ureaplasmas 
(13) and Spiroplasmas (14, 28). Acholeplasma laidlawii does not use the UGA codon for 
tryptophan, but continues to use UGA as a stop codon (241). 
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Translational termination in E. coli is mediated by two codon-specific protein factors, 
release factor 1 and release factor 2. Release factor 1 recognizes the stop codons UAA and 
UAG, and release factor 2 recognizes the stop codons UGA and UAA (20). Because the UGA 
codon is used for tryptophan in most mycoplasmas, it remains to be determined whether 
release factor 2 has been deleted or if release factor 2 has become specific for UAA. Moreover, 
it is not known if mycoplasmas use release factors because they have not been identified. 
The alternate codon usage of mycoplasmas creates two major problems in using E. coli to 
express mycoplasma genes. First, the UGA codon would be read as a translational stop in E. 
coli instead of a tryptophan resulting in truncated protein products (101). Unfortunately, some 
of the truncated protein products were not detectable with specific or convalescent antisera and 
thus escaped screening (13, 36,237). Second, different codon usage preferences and tRNA 
concentrations may interfere with translation (3). In E. coli, there is a positive correlation 
between codon frequency and the relative concentrations of corresponding tRNAs (160). Thus, 
mycoplasma genes may not be expressed or are expressed at low levels in E. coli because the 
necessary tRNAs may be limiting. 
Development of cloning systems in mycoplasmas 
The first cloning system for mycoplasmas was developed by Mahairas and Minion, and 
was based on the ability to integrate cloned genes into mycoplasmal chromosomes via 
homologous recombination (132,134). A cloning system involving two plasmids that share a 
region of homology such as an origin of replication and/or an antibiotic resistance marker was 
developed to simplify cloning steps (132). The cloning vectors are not able to replicate 
extrachromosomally in mycoplasmas. Thus, the plasmids must integrate into the chromosome 
in order to get expression and maintenance of the resistance marker. A recipient strain was 
created by transforming with one of the plasmids containing a mycoplasmal chromosomal 
DNA fragment. The plasmid integrated into the chromosome via homologous recombination 
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conferring antibiotic resistance (gentamicin or tetracycline) on the transformed cell. A second 
plasmid, containing the cloned gene of interest, was then used to transform the recipient strain. 
The second plasmid integrated into the previously integrated plasmid via homologous 
recombination. The presence of the second plasmid is selected for and maintained by a different 
antibiotic resistance marker than the one used to construct the recipient strain. Mahairas and 
Minion used the cloning vectors pSP64 (Promega Corp.) and pKS (Stratagene) (131,134), 
and attempted to express the PI gene and operon as well as a gene encoding a 31-kDa protein 
fcom Brucella abortus in Acholeplasma (132). Although integration into the chromosome of 
these genes was confirmed by DNA-DNA hybridization, the protein products were not detected 
by screening with antisera. More recent studies have confirmed the versatility of this system by 
introducing recombinant plasmids into M. gallisepticum (Cao and Minion, unpublished 
results). 
The primary advantage of this system is its versatility because any plasmid, whether it is 
of Gram positive or Gram negative origin, can be inserted into the chromosome. Thus, the 
cloning vectors can be shuttied between mycoplasmas and other cloning hosts. In addition, this 
system will accommodate DNA inserts of at least 15-kb and the inserted DNA is stable, even in 
the absence of selection (134). Because the cloned gene is integrated into the chromosome, it 
has a copy number of one or two. Thus, the copy number of the cloned gene would be similar 
to the way it is normally represented in the bacterial cell. If high levels of expression of the 
cloned gene were desired, higher gene copy numbers might be more advantageous, but high 
copy number plasmid cloning vectors are not presentiy available. The disadvantage of this 
system is the requirement that the cloning and amplification steps must occur in another cloning 
host due to the inherent limitations of the PEG transformation procedure. In addition, because 
the cloned insert can only integrate into one site in the chromosome, regulation in that region 
may also influence levels of gene expression. 
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Another cloning system has been developed in S. citri using the Spiroplasma spp. virus 
SpVl as a cloning vehicle (231). SpVl has a single-stranded DNA genome with a double-
stranded replicative form that can be used a cloning vehicle (188). Initially, Stamburski et al. 
cloned and expressed the E. coli chloramphenicol acetyl transferase (CAT) gene in S. citri 
(231). They were able to introduce cat at a frequency of 6 x 10^ transfectants/|J.g of DNA via 
electroporation. Moreover, the vector provided the promoter, translational start region, and 
termination sequence for the cat gene. In order to show that genes possessing a UGA codon 
would s tin be expressed, one TGG tryptophan codon of the cat gene was mutated to the stop 
codon TGA (232). The altered cat gene was expressed in S. citri, but not in E. coli. The 
system was then used to clone and express a 1.4-kb fragment of the PI gene of M. 
pneumoniae containing 7 UGA codons (140). Thus, this cloning and expression system has 
demonstrated the ability to express mycoplasmal genes. The advantages of this system include 
the proven ability to clone and express mycoplasmal genes, high transformation frequencies, 
high copy number of the recombinant in spiroplasmas, and an effective reporter gene, cat 
(187). The system's major disadvantage is instability. As the insert size increased, the ability to 
maintain and express the cloned gene decreased. In addition, there is a limited host range 
because the virus will only infect spiroplasmas. 
A third cloning system has utilized naturally occurring mycoplasma plasmids as cloning 
vectors (55,102). Unfortunately, there have been only three plasmids isolated from the genus 
Mycoplasma, and only two have been characterized (11, 104, 253). The mycoplasma plasmids 
pKMKl and pADB201 were both isolated from M. mycoides subsp. mycoides and belong to 
the family of Gram positive plasmids that replicate by a single-stranded intermediate (77,104). 
King and Dybvig have cloned the tetM gene from Tn9/(5 into plasmid pKMKl to generate 
plasmid pJI3, and they were able to introduce this plasmid into M. mycoides subsp. mycoides. 
This plasmid, however, was unstable and tended to delete portions of the plasmid (King and 
Dybvig, personal communication, 55). The potential advantages of this system remain to be 
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proven. While this system shows promise, there are precedents of plasmid instability using 
plasmids from Gram positive bacteria as cloning vectors (60,76, 77). 
It should be noted that broad host range Gram positive plasmids pVA868, pVA920, and 
pNZ18 have also been examined as potential cloning hosts in mycoplasmas (49, 239). 
Plasmids pVA868 and pVA920 were highly unstable and spontaneously deleted cloned 
fragments, whereas, pNZ18 was stable in A. laidlawii. A. laidlawii, however, uses UGA as a 
stop codon, offering no advantage over E. coli as a cloning host. These plasmids have not been 
shown to transform any of the other Mollicutes. Opal suppressor strains have also been 
examined as a means of obtaining full-length expression of mycoplasmal proteins in E. coli 
(Smiley and Minion, submitted; 189). 
Regulation of Gene Expression in Mycoplasmas 
The regulation of gene expression in mycoplasmas remains an enigma because of the lack 
of mycoplasma-based genetic systems to perform valid studies. Other cloning hosts such as E. 
coli, have been shown to be inappropriate for examining gene regulation (67). The present 
knowledge of gene regulation in mycoplasmas is based on models developed for other bacterial 
genes; it remains to be determined whether they will apply to mycoplasmas. Because 
mycoplasmas possess the smallest genomes necessary for autonomous existence, it is possible 
that they may also possess novel means of regulating their genes. 
Transcription in mycoplasmas 
Transcription, the synthesis of mRNA from a DNA template, occurs through the action of 
a DNA-dependent RNA polymerase following the specific recognition of a promoter sequence 
upstream of a gene or operon. The E. coli RNA polymerase holoenzyme is an 480-kDa protein 
that is composed of 4 subunits and can be divided into two components, the core enzyme («2, 
(3, p') and a sigma factor {a) (123). The a subunit is 40-kDa and is involved in promoter 
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binding. The 155-kDa |3 subunit is involved in nucleotide binding and the 160-kDa P' subunit 
is involved in template binding during elongation. The 85-kDa sigma subunit is involved in 
specific promoter recognition and is released once chain elongation has initiated (123). 
Mycoplasma RNA polymerase has been partially characterized from two genera. Gadeau et al. 
isolated spiroplasma RNA polymerase by running a purified cell lysate over a heparin-agarose 
column (66), The product was run on a SDS polyacrylamide gel and three major bands of 140, 
130-, and 38-kDa were present. The authors suggest that they correspond to the P, P', and a 
subunits, respectively, of the core enzyme. A partially purified M. capricolum fraction also 
revealed two large proteins of 140- and 130-kDa (160). 
A notable feature of the mycoplasma RNA polymerase is its insensitivity to the antibiotic 
rifampicin (66,219). Rifampicin binds to the P subunits of eubacterial RNA polymerase and 
prevents transcription initiation (123). Spiroplasma spp., A. laidlawii, and M. mycoides was 
shown to be 10 to 1,000 times more resistant to rifampicin than E. coli (66). Therefore, the 
structure of the mycoplasma RNA polymerase is similar to other eubacteria. The size or protein 
conformation of the individual subunits may differ because the mycoplasma RNA polymerase 
appeared to possess the same subunits as the E. coli RNA polymerase yet the mycoplasma 
RNA polymerase was resistant to rifampicin. 
The sigma factor of mycoplasma RNA polymerase has not been identified. The sigma 
factor is important because it confers promoter specificity on the transcriptional process (86). A 
number of bacteria, including E. coli and B. subtilis, have been shown to possess more than 
one sigma factor each recognizing a different set of promoters. By altering the sigma factor 
component in RNA polymerase, global changes in transcription can be initiated such as during 
a heat shock response or during induction of sporulation (92, 164,235). High temperature 
induced proteins that cross-react with the DnaK and GroEL heat shock proteins of E. coli have 
been identified in mycoplasmas (37). The presence of multiple mycoplasma sigma factors have 
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not been addressed, and it remains to be determined whether mycoplasmas respond to 
environmental changes. 
Promoters. The analysis of mycoplasma promoters has been based on the ability of 
upstream regions of mycoplasma genes to generate a product in E. coli and on transcriptional 
start site mapping studies (67). Defining a mycoplasma promoter by its ability to drive the 
expression of a gene in E. coli could be misleading because mycoplasma DNA, like E. coli 
promoters, is A + T-rich. It has been shown with another A + T-rich organism, Streptococcus 
pneumoniae, that strong promoter-acting sequences were commonly observed in randomly 
cloned DNA fragments in E. coli, and they occurred more frequently than in randomly cloned 
E. coli sequences (27). Thus, mycoplasma DNA may generate pseudo promoter activity in E. 
coli (159, 184). The mapping of transcriptional start sites by S1 nuclease or primer extension 
have merely shown where transcription begins and does not necessarily imply that the 
upstream regions at -10 and -35 are the mycoplasma RNA polymerase binding or recognition 
sites. 
Hawley and McClure analyzed over 110 E. coli promoter sequences and derived a 
consensus promoter sequence at regions -35 and -10 nucleotides upstream of the transcriptional 
start site (84). The -10 region or the consensus TATAAT is referred to as the Pribnow box 
(123). Unfortunately, relatively few mycoplasma genes have been sequenced, and most of the 
genes analyzed so far are rRNA, tRNA, and ribosomal protein genes (29,30,160). 
Comparison of mycoplasma regions upstream of the transcriptional start sites with the E. coli 
consensus promoter sequence showed that the -10 region was conserved, but the -35 region 
was more variable showing significant heterogeneity (29, 30). It should be noted that for the E. 
coli promoters examined by Hawley and McClure (84) 3.9 of 6 bases of the -35 consensus and 
4.2 of 6 bases of the -10 consensus promoter sequence matched. The observation of E. coli-
like promoters has been noted in other A + T-rich organisms, including B. subtilis and 5. 
pneumoniae (151, 156). Because the likelihood of randomly encountering an E. co/Mike 
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promoter sequence is high in these A + T-rich organisms (159), their RNA polymerases are 
expected to have a more stringent sequence requirement than does E. coli RNA polymerase 
(151, 156). There have been a number of attempts to develop a promoter search algorithm 
which would efficiently detect promoter sites within a large DNA sequence (158, 159, 171, 
173, 234). These programs have been based on the ability to detect E. coli promoters. 
Two models for the association of RNA polymerase with the -35 and -10 regions of the 
promoter have been offered. The bipartite model suggests that the -10 region is involved in the 
melting-in of the RNA polymerase near the transcriptional start site and the -35 region is 
involved in the specific recognition of the promoter by RNA polymerase (72). The other 
model, proposed by Stefano and Gralla, suggests that there is simultaneous recognition by the 
RNA polymerase at the -10 region, the -35 region, and the spacer elements between the two 
regions (233). Reznikoff and McClure, however, offer a more general model that a preferred 
promoter-RNA polymerase interaction exists for a given promoter, but that other influences 
such as ancillary proteins or supercoiling affect the ideal interaction between the promoter and 
RNA polymerase (192). 
The transcription initiation sites have been mapped for several of mycoplasma genes and 
they appear 6 to 8 bp downstream of the putative -10 region (67, 242, 243). This observation 
agreed with the distance reported for E. coli (180). The apparent conservation of the Pribnow 
box sequence and its distance from the start site in mycoplasmas has led investigators to 
suggest that the M. capricolum RNA polymerase recognizes promoter sequences resembling 
those in E. coli (67, 160). They supported their hypothesis with the observation that promoters 
of the rrnA and tRNA genes were recognized by E. coli RNA polymerase both in vivo and in 
vitro (67). This experiment does not prove their hypothesis, however. Their evidence, at best, 
merely indicates that the melting-in region (Pribnow box) and its distance from the start site 
have been conserved in mycoplasmas. Because of the variability at the -35 regions of 
mycoplasma promoters, it would be unwarranted to assume that this region is recognized by 
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the mycoplasma RNA polymerase until fine structure analysis of this region has been 
performed in mycoplasmas. 
Transcription initiation. Regulation of transcription initiation generally falls into 
two forms, negative and positive regulation. Moreover, several genetic regulatory systems 
have exhibited dual control effected by the same protein, with positive or negative regulation 
determined by the protein binding site relative to the promoter (reviewed in 192). Other means 
of regulating transcription initiation include DNA supercoiling (45, 178), DNA methylation 
(106), and altering the specificity of the RNA polymerase by substituting sigma factors (86). 
Positive and negative regulation are defined by the response of the operon when no 
regulatory protein is present. Genes under negative control are constitutively expressed unless 
they are switched off by a repressor protein. One model system of negative regulation is the lac 
operon (reviewed in 192). Negative regulation of the lac operon occurs via the lac repressor 
protein which binds to the operator region {lacO) located between the promoter {lacP) for lacZ 
and the translational start site of the structural gene. This prevents the RNA polymerase from 
forming an open complex to initiate transcription. The lac repressor is a tetramer of identical 38 
kDa subunits produced by lad, located upstream of lacP. Mutations in lad result in the 
constitutive phenotype irrespective of whether the inducer is present or not (148). The other 
component of this negative regulatory system is the inducer which binds the repressor causing 
an allosteric change in the configuration of the repressor, and reduces its affinity for the 
operator region. The inducer is a P-galactoside (e. g., lactose, allolactose, and isopropylthio-P-
galactoside or IPTG) which is the substrate for the lacZ product. 
Positive regulation at transcription initiation refers to the requirement for a protein factor 
that is called an activator or inducer (193). This protein may be an ancillary protein that allows 
RNA polymerase to initiate transcription at specific promoters, a factor tiiat replaces one of the 
subunits of RNA polymerase thus altering its promoter recognition specificity (i. e., sigma 
factor), or a new RNA polymerase (193). 
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Perhaps the best known example of an activator is the catabolite activator protein (CAP) or 
cyclic AMP receptor protein (CRP) which is activated in response to nutrient changes in E. coli 
(40) as well as other bacteria (193). E. coli preferentially utilizes glusose over other sugars as 
an energy source. For example, if both glucose and lactose were amply supplied in the 
medium, glucose would be preferentially metabolized and the use of lactose would be 
repressed in a response termed catabolite repression (40). Catabolite repression is initiated by 
the ability of glucose to reduce the level of cyclic AMP (cAMP) in the cell by an unknown 
mechanism. But if cAMP levels are high, it can bind to the CAP rendering it capable of 
assisting RNA polymerase in transcription initiation. The CAP-cAMP complex has been 
shown to activate the pap operon which codes for type P pilus in E. coli, and consequentiy, is 
involved in regulation of virulence factors (reviewed in 245). 
For the lac operon, DNase protection assays demonstrated that the complex of cAMP-CAP 
bound just upstream of lacP and protected nucleotides -87 to -49, whereas, the RNA 
polymerase protected nucleotides -48 to +5 (191). Because the presence of CAP stimulated the 
initiation of lac mRNA synthesis by 50-fold and because the CAP protein was adjacent to the 
RNA polymerase binding region, it is believed that the CAP provides an additional binding site 
for RNA polymerase (192). The protein-protein interaction acts to either stabilize the RNA 
polymerase-DNA complex or induces a favorable conformational change in the RNA 
polymerase. Another hypothesis is that CAP induces a change in the DNA that enhances the 
ability of RNA polymerase to bind (190). It should be noted that the lac repressor has been 
shown to bind to nucleotides -3 to +21 which overlapped the RNA polymerase binding site. 
Thus, this finding supports the notion that the repressor prevents the binding of RNA 
polymerase (191, 192). 
Regulation of transcription initiation has not been demonstrated in mycoplasmas. Muto et 
al. suggested that most of the genes encoded within the mycoplasma genome are constitutively 
expressed because the genome only possesses genes that are necessary for growth (160). 
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Moreover, they asserted that the negative control elements used by other eubacteria in response 
to environmental changes may not be required in mycoplasmas. They believed that gene 
regulation in mycoplasmas is a quantitative mechanism of gene regulation rather than an on or 
off switch for gene expression. They proposed that the quantitative regulation is similar to the 
stringent control response that regulates the levels of many housekeeping genes in E. coli in 
response to poor growth conditions (reviewed in 19). 
Stringent control is an adaptive response that is part of a global regulatory network 
activated in response to amino acid starvation (19). The stringent response results in a 10- to 
20-fold reduction in rRNA and tRNA synthesis, and a 3-fold reduction in mRNA synthesis. 
The response is triggered by the presence of an uncharged tRNA in the A site of the ribosome 
during translation. The major regulatory signals in this response are guanosine tetraphosphate 
(ppGpp) and guanosine pentaphosphate (pppGpp) which act as negative regulators of 
transcription initiation and/or elongation. Stringently controlled promoters in E. coli contain a 
conserved G + C-rich discriminator region just 3' to the -10 region of the promoter at -5 to +2 
(248). Similar regions have been described in other bacteria including Salmonella typhimurium 
and B. subtilis (248). A similar G + C-rich discriminator region does not appear to be present 
in mycoplasmas because M. capricolum rrnA was activated rather than repressed in the 
presence of high levels of ppGpp in E. coli (67). This suggests that the control mechanism is 
different from that in E. coli. 
In addition to the discriminator region in E. coli, A + T regions centered at -70 and -51 
were found to be conserved in rRNA upstream regions (248). It has been shown in both E. 
coli and mycoplasmas that the region upstream of the -35 region affects levels of gene 
expression (R. Herrmann, University of Heidelberg, personal communication; 99). 
Transcription termination and attenuation. Regulation of gene expression at the 
level of transcription termination also occurs in bacteria. The termination signals generally fall 
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into three categories: simple (rho-independent) terminators, attenuators, and rho-dependent 
terminators (reviewed in 175, 262). 
The simple terminators consist of a series of uridine residues at the 3' end of the transcript 
which are preceded by a G + C-rich region of dyad symmetry capable of forming a hairpin 
loop (262). It has been shown that base analog substitutions or point mutations that strengthen 
or weaken the hairpin structure increase or decrease, respectively, the termination signal (175). 
The polyuridine region facilitates dissociation of the transcript from the template. Rho-
independent terminator-like structures have been reported for the rRNA, tRNA, and ribosomal 
protein genes of M. capricolum that possess A + T-rich hairpin loops instead of the G + C-rich 
sequences in E. coli (161, 172, 215). In contrast, it has been shown that the transcription 
terminator of spiroplasmas possess G + C-rich hairpin structures (28, 206, 230). Thus, there 
appears to be a difference in the termination signals used by mollicutes, and the transcriptional 
terminators should be a consideration when developing a cloning system to express 
mycoplasma genes. 
An attenuator is a transcription termination site located within an operon that acts to 
regulate the expression of the operon's gene product (266). This type of regulation is 
associated with amino acid biosynthesis such as the histidine, isoleucine, leucine, 
phenylalanine, threonine, and tryptophan opérons (175). The trp operon has been the model 
system in studying attenuation in E. coli (266). Similar attenuator-like sequences have been 
described for tRNA operon coding for tRNAs that recognize the UG A and UGG codons for 
tryptophan (264, 265). The attenuator-like sequence is located between the two tRNA genes 
and results in a 5-fold decrease in the level of the tRNAuGG- This correlates with the 5- to 10-
fold difference in which these codons are used by the cell (263, 264). 
Rho-dependent termination, unlike simple termination, requires the protein rho (p) factor 
for transcription termination (175). Rho factor's role in transcription termination is unclear 
because a consensus rho-binding site has not been determined. The hairpin structure of a rho-
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dependent terminator is not necessarily G + C-rich, nor is there a polyuridine region 
downstream. There is usually an 80-bp region upstream of the hairpin that contains 
pyrimidines (usually C) in the third position of every fourth codon. It is suggested that the rho 
protein winds itself up in the transcript via attachment to these pyrimidine residues in an ATP-
dependent manner resulting in transcription termination (175). Rho-dependent tennination has 
not been reported for mycoplasmas, but J. M. Bove (University of Bordeaux) has indicated 
that spiroplasmas may exhibit rho-dependent termination (9th International Organization for 
Mycoplasmology). 
Promoter probe vectors. Promoter probe vectors provide a means of identifying or 
locating DNA sequences containing promoters in vivo. Generally, they are designed with 
unique cloning sites located upstream of a promoterless gene encoding an assayable and/or 
selectable function such as lacZ ((3-galactosidase) (221), galK (galactokinase) (210), cat 
(chloramphenicol acetyltransferase) (78), gusA (^-glucuronidase; GUS) (68), lux (luciferase) 
(22^),phoA (alkaline phosphatase) (138), or an antibiotic resistance marker (240). 
Introduction of the promoter probe vector into a cell should result in a null phenotype because 
no promoter is present If a fragment containing a promoter in the proper orientation is cloned 
upstream of the reporter gene, the reporter gene's phenotype should be expressed. 
lac fusions have been shown to be useful in a variety of applications (reviewed in 221). 
These applications include; 1) the study of the regulation of a gene or operon, 2) the detection 
of genes that respond to a particular regulatory signal, 3) the study of the localization of a 
protein within the cell, and 4) the detection of a protein or gene and the ability to assay for the 
protein or gene when no assay for the gene product exists. In addition, lac fusion vectors have 
been widely used because the biochemical and genetic aspects of the lac operon have been well 
studied and there are a number of indicator media available for detection of p-galactosidase 
activity (221). Gronenbom and Messing (75) removed the lacZ gene regulatory elements by 
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introducing an fîcoRI site at the fifth codon, and Casadaban et al. (17) introduced a BamYH site 
at the eighth codon. Expression of the truncated lacZ gene requires that cloned upstream 
sequences possess a promoter, ribosomal binding site, and translational start codon. Operon 
fusion vectors have also been constructed using lacZ and a truncated trp promoter (16). The 
truncated trp promoter possesses only the translational elements, so that the cloned upstream 
fragment need only provide the promoter in any reading frame. Operon fusion vectors, 
however, have been difficult to use because of high background expression when placed on a 
high copy number plasmid. To avoid the high background, Simons and Kleckner introduced a 
transcription termination signal upstream of lacZ to avoid read-through from adjacent genes 
(223). 
In addition to plasmid based promoter probe vectors, transposable elements carrying lacZ 
have been used to detect promoters directly on the chromosome. These vectors include 
derivatives of Mu phage, Mu dlacl and 2 (18) and X plac Mu (108), and many transposons 
such as Tni (229), Tn70 (256), Tn5 (113), and Tn9/7 (268). These vectors are able to locate 
promoters in the chromosome by inserting into regions of active transcription and/or translation 
which drive the expression of the reporter gene carried within the transposon. 
Translation in mycoplasmas 
The mechanisms of translational regulation in mycoplasmas are merely speculation at this 
point because of a lack of study. Genetic systems are not available to study translation in 
mycoplasmas. Like other aspects of gene regulation previously discussed, the precise regions 
involved are hypothetical based on observations made in other bacterial systems. The probable 
ribosomal binding sites, as well as translational start sites, for over twenty M. capricolum 
ribosomal genes have been reported (172). In addition, the probable translational start regions 
for a number of spiroplasmal proteins (28), the arginine deiminase gene of M. arginini (110), 
and the urease gene of U. urealyticum (13) have been reported. All of these genes appeared to 
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use AUG as a start codon except for 1 gene of unknown function in S. citri (28). Moreover, 
there appeared to be ribosomal binding sites at the proper distance (5 to 9 nucleotides) upstream 
of the start site. 
The 3' ends of the 16S rRNA sequence of M. capricolum and S. citri have been described 
and were shown to be identical (28, 97). Moreover, the last 15 nucleotides of the 3' ends of the 
16S rRNA genes of these mycoplasma species are identical to the last 15 nucleotides of the 16S 
rRNA gene of 5. subtilis and have a 12-nucleotide homology with E. coll 16S rRNA (28). 
Thus, at the sequence level, the translational initiation regions of mycoplasmas appear to be 
similar to those of E. coli and B. subtilis. A report by Notarnicola et al. (170) has even made 
the issue involving mycoplasma translational start regions more confusing. They observed 
translational initiation inside a mycoplasma coding sequence in E. coli. 
The ability to clone and express Gram positive genes in Gram negative bacteria has been 
reported to occur efficiently, but the ability to clone and express Gram negative genes in Gram 
positive bacteria has been inefficient (81). One possible reason for the difference in the ability 
to express genes from Gram negative bacteria in Gram positive is the differences in binding 
stringencies of their respective ribosomes and mRNA (81, 143). The base pairing of the 16S 
rRNA with the ribosomal binding sites of E. coli had a generally lower free energy of binding 
than that of ribosomes and mRNA of Gram positive bacteria. 
Differences in the stringency of binding of 16S rRNA and the ribosomal binding sites 
between Gram positive and negative bacteria cannot account for all the differences in the ability 
to express in the heterologous host. Hager and Rabinowitz showed that T7 genes, which 
possess a long ribosomal binding site, were not translated as well by B. subtilis ribosomes as 
genes from the B. subtilis phage (j)29 that has the same ribosomal binding site as T7 genes (80, 
81). Because the spacing between the ribosomal binding sites and the start sites was nearly 
identical, the authors suggested that the difference in translation efficiency was due to 
secondary structure or interaction with the ribosome at another region in the transcript. 
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Secondary structure of the 5' untranslated region of the gltBDF operon of E. coli has been 
shown to regulate expression (252). Also, enhancing sequences recognized by the ribosome 
located within the 5 to 9 nucleotide spacer, 5' of the ribosomal binding site, or 3' of the 
translational start site have been reported (reviewed in 141). 
Loechel et al. have reported that they have identified a novel translational initiation region 
from M. genitalium that functioned in E. coli (128). The efficiency of this translation initiation 
was affected by the secondary structure around the site as well as sequences upstream and 
downstream of the translational start site. Therefore, it appears that secondary structure of the 
translation initiation region, as well as enhancer-like sequences, may also affect the ability to 
translate genes in mycoplasmas. 
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MATERIALS AND METHODS 
Bacterial Strains and Culture Media 
The strains and plasmids used in this study are listed in Table 1. Acholeplasma strain 
designations ISM2004-2010, or ISM2050.X and ISM1499.2050.X represent mycoplasma 
recombinants containing plasmids pISM2004-pISM2010 or pISM2050.X, respectively. The X 
suffix designates a derivative of the parent lacZ fusion vector, pISM2050, containing a cloned 
Acholeplasma chromosomal DNA fragment. Fragment sizes of these cloned fragments are 
given in Table 1. Strain IS M1499 is a laboratory isolate that has been serotyped by J. G. Tully 
(NIAID) to be related to Acholeplasma oculi and Acholeplasma laidlawii. All references to M. 
pulmonis ISM1499 should be regarded as Acholeplasma ISM 1499. 
Acholeplasma strains were grown in PPLO broth (Difco Laboratories, Detroit, Mich.) 
supplemented with 15% gamma globulin-free horse serum (GIBCO Laboratories, Grand 
Island, N.Y.), 2.5% yeast extract, 0.5% glucose, 2.5 |i.g/ml of Cefobid (Pfizer, Inc., New 
York, N.Y.), 0.02% herring sperm DNA (Sigma Chemical Co., St. Louis, Mo.), 0.002% 
phenol red, and (when required) 1% Noble agar (Difco). Selective levels of antibiotics for 
Acholeplasma ISM 1499 were 2 ng/ml tetracycline (Sigma) and 15 |ig/ml gentamicin (Sigma), 
and resistant cultures were maintained at 10 |J.g/ml tetracycline and 15 to 20 |J.g/ml gentamicin. 
E. coli cultures were grown in Luria broth containing 100 Hg/ml ampiciUin (Sigma) or 12.5 
jig/ml tetracycline when appropriate. 
Reagents and Buffers 
Restriction enzymes (RE), T4 DNA ligase, and Klenow enzyme were purchased from 
Promega Corporation (Madison, Wis.) or GEBCO BRL (Gaithersburg, Md.) and used 
according to manufacturer's instructions. 5-bromo-4-chloro-3-indolyl-|3-D-galactoside (X-gal) 
(GIBCO BRL or Gold Biotechnology, Inc., St. Louis, Mo.) was used at a concentration of 
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Table 1. Bacterial strains and plasmids 





















(t)80d/acZAM15 enclAI recAl hsclRl? supE44 thi-I BRL 
gyrA relAl F" A(lacZYA argF)U 169 
ara DQac-pro) strA thi F" (147) 
CSH50(pISM2050.X) This study 
F- supE42 X- TSr R. Curtiss III 
recAl, lac, endAl, gyrA96, thi, hsdRIV, supE44, Stratagene 
relAl [F proAB, lacfi, /acZAM15, Tn70] Tc^ 
Laboratory isolate This study 
ISM 1499 with integrated plasmid X Gm^ This study 
ISM 1499 with integratedpISM1026 Tc^ (132) 
ISM1520 with integrated plasmind X Gm^ Tc^ This study 
trp-lacZYA Km^ (41) 
Multipurpose cloning vector Ap*" Stratagene 
Prokaryotic fusion vector Tc^" Pharmacia 
Multipurpose cloning vector Ap^ Promega 
Multipurpose cloning vector Ap^ Promega 
pKS' containing the 3.1 -kb lacZ fragment from This study 
pMC1871 in which the downstream 5fl/nHI RE site 
has been altered Ap^ 
^Apf, Tc^, Gm^, and Kmi" denote resistance to ampicillin, tetracycline, gentamicin, and 
kanamycin, respectively. RE denotes restriction endonuclease. 
bx denotes the plasmid designation which was then used to denote the strain designation 
(e.g.. Strain ISM2050.1 = ISM 1520 with pISM2050.1, Strain ISM 1499.2050.1 = ISM1499 
with pISM2050.1, and Strain CSH50.2050.1 = CSH50(pISM2050.1). 
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13.5-kb plasmid containing Tn4001 Ap^ Gm^" 
5.75-kb plasmid containing the gentamicin resistance 
marker from Tn4001 Gm^ Ap^ 
pISM1003 with M. capricolum rniA P2 promoter Gm'" 
Ap^ 
pis M1003 with E. coli rniB PI promoter Gm^ Ap^" 
pISM1003 with trp-lacZYA Gm^ Ap^ 
pISM2002 with trp-lacZYA Gm^" Ap^ 
pISM2003 with trp-lacZYA Gm^ Ap^" 
pISM2G04 with E. coli rrnB PI promoter containing 
700 bp of the upstream region of the M. capricolum 
rrnB P2 promoter Gm^ Ap^ 
pISM2004 with M. capricolum rrnA P2 promoter 
containing 700 bp of the upstream region of tetM. 
capricolum rrnB P2 promoter Gm^ Ap^ 
pISM2004 with E. coli rrnB PI promoter containing 
700 bp of the upstream region of the M. capricolum 
rrnB P2 promoter in the reverse orientation Gm^ Ap"" 
pISM2004 with M. capricolum rrnA P2 promoter 
containing the -35 region of the E. coli rrnB PI 
promoter and the -10 region of tetM. capricolum rrnB 
P2 promoter Gm^" Api" 
pISM2012 containing the trp-lacZYA Gm^ Ap^ 
10.3-kb rescue plasmid derivative of pSP64 containing 
the tetM from Tn916 and the gentamicin resistance 
marker from Tn-^OO/ Ap^ Tc^ Gm^ 
pISM2002 containing the B52 adhesion gene from M. 
pneumoniae Ap^" Gm^ 
pISM2002 containing the B52 adhesion gene from M. 

















Table 1 .(continued) 
pISM2032 pISM2008 containing the B52 adhesion gene from M. This study 
pneumoniae Api" Gm^" 
pISM2033 pISM2008 containing the B52 adhesion gene from M. This study 
pneumoniae in the reverse orientation Ap*" Gm^ 
pISM2034 pISM2002 containing the PI adhesion gene from M. This study 
pneumoniae Ap^ Gm*" 
pISM2035 pISM2002 containing the PI adhesion gene from This study 
pneumoniae in the reverse orientation Ap*" Gm'" 
pISM2036 pISM2008 containing the PI adhesion gene from M. This study 
pneumoniae Ap^ Gm^ 
pISM2037 pISM2008 containing the PI adhesion gene from M. This study 
pneumoniae in the reverse orientation Ap^ Gm^ 
pISM2046 pKS" with BamWl and Sma\ RE sites removed Ap^ This study 
pISM2048 pISM2046 containing a 1.3-kb fragment containing the This study 
ca. 1-kb distal end of an \S256 arm oiTn400I Ap^ 
pISM2048.5 pISM2048 with the insertion of BamWl and Smal RE This study 
sites ca. 30 bp from the distal end of an IS256 arm of 
TïAOOl Ap^ 
pISM2050 Promoterless lacZ fusion vector Gm^ Ap'" This study 
pISM2050.1 pISM2050 with 2.8-kb of ISM 1499 chromosomal This study 
DNA Gmi"Ap^ 
pISM2050.2 pISM2050 with 0.9-kb of ISM 1499 chromosomal This study 
DNA Gm^ApT 
pISM2050.8 pISM2050 with 1.0-kb of ISM 1499 chromosomal This study 
DNA Gm^Apr 
pISM2050.18 pISM2050 with 0.9-kb of ISM 1499 chromosomal This study 
DNA Gm^'Ap'" 
pISM2050.19 pisM2050 with 1.5-kb of ISM 1499 chromosomal This study 
DNA Gm^Ap^ 
pISM2050.25 pISM2050 with 0.8-kb of ISM 1499 chromosomal This study 
DNA Gm^Apr 
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pISM2050 with 1.0-kb of ISM 1499 chromosomal This study 
DNA Gmr Apr 
pISM2050 with 1.7-kb of IS M1499 chromosomal This study 
DNA Gmr Apr 
pISM2050 with 2.0-kb of ISM1499 chromosomal This study 
DNA Gm^Apr 
pISM2050 with 2.5-kb of IS M1499 chromosomal This study 
DNA Gm^ Apr 
pISM2050 with 2.3-kb of IS M1499 chromosomal This study 
DNA Gmr Apr 
pISM2050 with 2.2-kb of ISM1499 chromosomal This study 
DNA Gmr Apr 
pISM2050 with 1.0-kb of ISM1499 chromosomal This study 
DNA Gmr Apr 
pKS' containing a 5.8-kb Pstl-Sacl fragment from This study 
pISMlOOl harboring Tn400/ Apr Gmr 
pISM2061 containing the BawHi. and Smal RE sites in This study 
an IS25d arm of Tn4001 Apr Gmr 
pISM2062 containing the 3.1-kb lacZ fragment from This study 
pMC1871 Apr Gmr 
pISM2062 with two translational stop codons altered This study 
ApT Gmr 
pISM2062 with three translational stop codons altered This study 
Apr Gmr 
pISM2062.2 containing the 3.1 -kb lacZ fragment from This study 
pMC1871 Apr Gmr 
pISM2062.2 containing the 3.1-kb lacZ fragment from This study 
pMC1871 in the reverse orientation Apr Gmr 
pISM2062.3 containing the 3.1 -kb lacZ fragment from This study 
pMC1871 Apr Gmr 
Table 1. (continued) 
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pISM2062.3/ac(rev) pISM2062.3 containing the 3.1-kb lacZ fragment from This study 
pMC1871 in the reverse orientation Ap^ Gm*" 
pISM2064 pISM2062.2 containing pISM205 Ap'" Gm^ This study 
pISM2065 pISM2062.3 containing pISM205 Ap^ Gm'" This study 
pISM2075 Exo/Mung deletion clone of pISM2050.2 Lac" Ap^ This study 
Gm^ 
pISM2076 Exo/Mung deletion clone of pISM2050.2 Lac"*" Ap^ This study 
Gmf 
pISM2077 Exo/Mung deletion clone of pISM2050.2 Lac"*" Ap^ This study 
Gmf 
pISM2078 Exo/Mung deletion clone of pISM2050.2 Lac+ Ap^ This study 
Gmf 
pISM2079 Exo/Mung deletion clone of pISM2050.2 Lac"*" Ap^ This study 
Gmf 
pISM2080 Exo/Mung deletion clone of pISM2050.2 Lac"^ Ap^ This study 
Gmr 
pISM208I pKS containing a 1.4-kb fragment harboring the 16S This study 
rRNA gene of ISM 1499 Ap^ 
pISM2083 pSP71 containing the promoter containing insert from This study 
PISM2050.2 Apr 
80 |U.g/ml when scoring for the Lac+ phenotype in Acholeplasma or 25 |lg/ml in E. coll All 
other chemicals and reagents were obtained from Sigma except where noted. Isopropylthio-P-
D-galactoside (GEBCO BRL or Gold Biotechnology) was used at a final concentration of 10 
mM. Oligonucleotides were synthesized by the Iowa State University Nucleic Acid Facility. 
Transformation of Acholeplasma spp., M. gallisepticum, and E. coli 
The transformation of Acholeplasma was performed as described previously (134). 
Mycoplasma gallisepticum was transformed via electroporation using the BTX model 600 
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electroporator (Biotechnologies & Experimental Research, Inc., San Diego, Cal.), using 2 mm 
gap cuvettes, with settings of 2.5 kV, 50 |J.F, and 129 ohm, to generate a pulse length of 5 
msec. Mid-log phase cells were washed 3 times with prechilled electroporation buffer (272 mM 
sucrose, 8 mM HEPES, pH 7.4). After the final wash the cells were resuspended in one-fourth 
to one-tenth the original culture volume with electroporation buffer and placed on ice. One 
hundred microliters of cells were mixed with 20 |il of electroporation buffer containing 7 to 10 
Hg of DNA and placed in the cuvette on ice. After a 10 min incubation the mixture was pulsed. 
The cells were immediately resuspended in 1 ml of complete PPLO media, transferred to a 
prechilled microfuge tube, and incubated on ice for 10 min. The cells were incubated at 37°C 
for 0 to 2 hr prior to plating. X-gal was spread on the agar surface 1 to 2 h prior to plating the 
mycoplasma transformation mixture. Blue colonies were picked and analyzed for P-
galactosidase (P-gal) activity. Transformation of E. coli was achieved by the method of 
Hanahan (82) or by electroporation using cuvettes with a 1 mm gap, settings of 0.81 kV, 50 
uF, and 129 ohm, to generate a pulse length of 5 msec. 
Preparation of Acholeplasma ISM1499 Chromosomal DNA 
Chromosomal DNA was prepared by washing the cells isolated from a 500 ml culture by 
centrifugation (10,000 x g, 15 min) with phosphate buffered saline (PBS, 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4) and resuspending the pellet in 5 ml of NET buffer (0.15 M 
NaCl, 0.08 M ethylene diamine tetraacetic acid (EDTA), 0.1 M Tris, pH 7.5) containing 10 
mg/ml Proteinase K. After a 2 h incubation at 37°C, the cells were lysed with 1 ml of a 
detergent solution containing 1% sodium dodecyl sulfate (SDS), 1% Nonidet P-40, and 1% 
deoxycholate. The DNA was extracted with phenol until the interface between the organic and 
aqueous phases was clear. The DNA was then extracted once with phenol-chloroform. The 
DNA was purified on a cesium chloride-ethidium bromide buoyant density gradient (213). 
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DNA bands were collected, ethidium bromide extracted, and salt removed as described 
previously (213). 
The chromosomal DNA was partially digested with Sau3Al and fragments were separated 
by a sucrose gradient as described previously (213). One-to six-kilobase fragments were 
isolated and cloned into pISM2050 using standard recombinant DNA techniques. 
Plasmid Constructions 
Construction of M. capricolum promoter-trp'-lacZYA translational fusions 
The -35 and -10 regions of the M. capricolum rrnA P2 promoter or the -35 and -10 
regions of the E. coli rrnB PI promoter (87) were cloned into the ficoRI and BamHl sites of 
plasmid pISM1003 (133) to generate plasmids pISM2002 or pISM2003, respectively. 
Plasmids pISM2005 and pISM2006 were constructed by inserting the 7.1-kb BarrMï fragment 
containing trp'-lacZYA from plasmid pDIA15 (41) downstream of the promoters in plasmids 
pISM2002 and pISM2003. Plasmids pISM2010 and pISM2009 are identical to plasmids 
pISM2005 and pISM2006, respectively, except that an additional 700-bp region upstream of 
the M. capricolum rrnB P2 promoter has been placed upstream of the promoters. Plasmid 
pISM2011 is identical to plasmid pISM2010 except that the M. capricolum promoter and rrnB 
P2 upstream sequences are in the reverse orientation. 
Construction of pISM2062 by using site-directed mutagenesis via the 
polymerase chain reaction (PCR) 
The Smal and BamWl RE sites were placed into an lS25d arm of Tn^OO/ by using 
oligonucleodde-directed mutagenesis via PCR, generating plasmid pISM2048.5. The mutant 
oligonucleotide primer, 5' TTGTGTAAAAGTCCCGGGGATCCAAAAAGGCCATAT-3', 
and the T3 primer provided with the plasmid pKS" were used to synthesize a 1-kb fragment 
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flanked with HinàBl and BamVO. RE sites. The complementary mutant oligonucleotide primer, 
5'-ATATGGCTTTTTGGATCCCCGGGACTTTTACACAA-3', and the T7 primer were used 
to synthesize a 300-bp fragment flanked with BamRl and Pst\ RE sites. The DNA fragments 
were generated with a Coy Tempcycler. One hundred nanograms of each primer was added to 
50 ng of template (pISM2048) and the PGR was run using the following program: four cycles 
of 7 min denaturation at 94°C, 10 min cooling, 5 min annealing at 25°C and 4 min of 
polymerization at 72°C; twenty cycles of 90 s denaturation at 94°C, 90 s annealing at 48°C, and 
2 min of polymerization at 72°C; and one cycle of 90 s denaturation at 94°C, 90 s annealing at 
48 °C and 7 min of polymerization at 72°C. 
Construction of the promoter probe vector, pISM2050 
Plasmid pISM2050 is a derivate of plasmid pISM1003 (133). Plasmid pISM1003 was 
digested with BamlQ. and the 3.1-kb BamHl fragment of plasmid pMC1871 (16) containing a 
promoterless lacZ gene was ligated into the site. In order to generate a unique BamHl RE site 
for cloning, the downstream BamHl site was removed by partial digestion with BamHl 
followed by a fill-in reaction with Klenow fragment of DNA polymerase I, ligation to 
circularize, and transformation into E. coli. Transformants were selected on ampicUlin-
containing media, and the proper construct was confirmed by restriction enzyme analysis. 
Plasmid pISM2050 was constructed with a gentamicin marker for selection in 
mycoplasmas, a promoterless lacZ reporter gene with unique upstream BamHl and Sma\ RE 
sites for cloning SûmSAI and blunt end fragments, respectively, and an ampicillin marker and 
origin of replication for amplification of DNA in E. coli prior to transformation into 
Acholeplasma. The ampicillin gene and origin of replication also provided a region of 
homology to insert the plasmid into the Acholeplasma recipient strain ISM 1520 via 
homologous recombination (134). 
43 
Preparation of RNA and Measurement of mRNA Levels 
Total RNA from a 5 to 10 ml overnight culture was prepared using RNA STAT-60 
isolation reagent (guanidinium thiocyanate-phenol mixture) (Tel-Test "B", Inc., Friendswood, 
Tex.) according to manufacturer's instructions . Messenger RNA levels were measured by slot 
blot analysis using a Minifold II apparatus (Schleicher & Schuell, Keene, N.H.) and the 
procedure described previously (213). Two micrograms of total RNA were placed into each 
slot and transferred to nitrocellulose (Schleicher & Schuell) and probed with a 1.4-kb fragment 
containing the 16S rRNA gene from ISM 1499 or a 3-kb fragment containing the lacZ gene. 
The blot was exposed to X-ray film or was examined with a Phosphorlmager and analyzed 
with the ImageQuant program (Molecular Dynamics, Sunnyvale, Calif.). Levels of the lacZ 
mRNA were adjusted by normalizing to the 16S rRNA levels to account for differences in 
amounts of RNA that may have been loaded in each slot for each strain. 
P-galactosidase Assays 
P-galactosidase assays were performed as described by Schleif and Wensink (217). 
Briefly, 5 ml of an Acholeplasma culture was washed once with PBS and the pellet was 
resuspended in 2 ml of Z buffer (0.1 M sodium phosphate, pH 7.0; 0.001 M magnesium 
sulfate; 0.1 M 2-mercaptoethanol). Fifty microliters of 0.1% SDS were added to 1 ml of the 
cell suspension and vortexed for 15 sec. One hundred microliters of the lysed cell suspension 
were added to 1 ml of Z buffer and equilibrated to 37°C. In order to examine the P-gal activity 
of an unlysed cell preparation, 100 |al of the remaining cells suspended in Z buffer were added 
to another 1 ml of Z buffer and similarly equilibrated to 37°C. Two hundred microliters of a 4 
mg/ml o-nitrophenyl-P-D-galactopyranoside (Sigma) solution were added. The reaction was 
stopped by adding 0.5 ml of 1 M sodium carbonate. The absorbance of the reaction was 
measured with a Spectronic 20 (Bausch & Lomb) at an absorbance of 420 nm. E. coli cultures 
were assayed similarly except that 100 |il of a 1 ml culture was used, and the cells were 
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permeabilized with 0.1% SDS and a couple of drops of chloroform. Fully induced E. coli 
strain %289 was used as a positive control. 
Protein concentration was measured by using the Bio-Rad protein assay (Bio-Rad, 
Richmond, Calif.) according to the manufacturer's directions. The number of colony forming 
units (CPU) per milligram of protein was determined by dividing the number of CPU/ml by 
mg/ml from the average of three cultures each measured in triplicate. The amount of P-gal 
enzyme required to give an OD = 1.0 at an absorbance of 420 nm in one minute is 4.45 x 10^2 
monomers (217). The levels of P-gal activity, therefore, was expressed as the number of 
monomers per CPU as shown below. Cultures were assayed in triplicate. 
Units of P-gal activity = A420 x 4.45 x 10^^ monomers 
time (min) x mg protein x CPU/mg 
Immunoblot Analysis 
Protein samples containing 25 jig protein from washed mycoplasmas were resuspended in 
water and lysed with 0.01% (final concentration) SDS, SDS-PAGE sample buffer (116) was 
added, the samples were boiled for 5 min and then separated on a 7.5% polyacrylamide 
resolving gel. Following electrophoresis for 4 h at 25 mAmp constant current, proteins were 
transferred to nitrocellulose following the procedure of Towbin (247). The blots were analyzed 
using a 1:3,000 dilution of a monoclonal antibody to P-gal (Promega) followed by goat anti-
mouse antibody conjugated to alkaline phosphatase (Kirkegaard & Perry Laboratories, Inc., 
Gaithersburg, Md.) (1:1,000 dilution). The blot was developed by using the BCIP/NBT one 
component alkaline phosphatase substrate system (Kirkegaard & Perry Laboratories, Inc.). 
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DNA Sequencing 
The mycoplasma chromosomal DNA driving the expression of the lacZ gene was 
sequenced using the Sequenase Kit Version 2.0 (United States Biochemical) or was sequenced 
by the Nucleic Acid Facility at Iowa State University. The sequencing primer was an 
oligonucleotide that was 30 bases long (30-mer) (5'-GCTGGCGAAAGGGGGATGTGCTGC 
AAGGCG-3') that is reverse and complimentary to the lacZ gene at approximately 50 
nucleotides downstream of the /acZ-chromosomal DNA fusion point. The mycoplasma inserts 
were sequenced by either isolating the insert from a gel or subcloning the fragment into pSP71, 
because pKS also possessed lacZ sequences. The inserts isolated from a 0.6% Tris acetate 
agarose gel were purified by GeneClean (San Diego, Calif.). The fragments were subcloned 
into either the Clal or ClallHindSXL RE sites of pSP71. The plasmid pSP71 derivatives were 
purified using Qiagen (Qiagen Inc., Chatsworth, Calif.) plasmid purification columns. Double-
stranded DNA was denatured in 0.2 M NaOH, 0.2 mM EDTA at 37°C for 30 min. Following 
ethanol precipitation, the DNA was resuspended in 7 |J.I H2O. The sequencing reaction was 
conducted as described by the manufacturer. Approximately 20 ng of the primer was used for 
each sequencing reaction. 
Primer Extension Analysis 
The transcriptional start sites of the lacZ fusion constructs were determined by using 
primer extension following the protocol described elsewhere (4). Briefly, 10 jll total RNA 
(containing 10 to 100 |ig RNA) were mixed with 1.5 |J,1 lOX hybridization buffer (1.5 M KCl, 
0.1 M Tris, 0.01 M EDTA, pH 8.3) and 3.5 fil of primer end-labeled with [Y-32p]ATP. After 1 
min at 90°C, the mixture was placed at 65°C for 90 min and then cooled slowly to room 
temperature. To each primer extension reaction a mixture containing 0.9 |il 1 M Tris (pH 8.0), 
0.9 |il 0.5 MgCl2, 0.25 |ll 1 M dithiothreitol, 6.75 fll of 1 mg/ml actinomycin D, 1.33 )ll of 5 
mM deoxynucleotide mix (all 4 deoxynucleotides), 20 |a,I H2O, and 0.2 |il of 25 U/|J.l avian 
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myeloblastosis virus (AMY) reverse transcriptase was added. After an 1 h incubation at 42°C, 
RNase A was added to a final concentration of 15 |ig/ml and incubated for an additional 15 min 
at 37°C. The DNA was resuspended in 3 to 5 |i.l of TE (0.01 M Tris, 0.001 M EDTA, pH 8.0) 
buffer following ethanol precipitation. Three microliters of the primer extension product were 
electrophoresed on an 8% acrylamide sequencing gel. As a reference, a sequencing reaction of 
the upstream lacZ fusion region with the sequencing primer was loaded beside the primer 
extension product The primer extension product was also compared to a sequencing ladder 
generated from pISM2083 using the sequencing primer. 
Exo/Mung Deletion Analysis of the pISM2050.2 Insert 
Plasmid pISM2050.2 was digested with Pstl and Smal restriction enzymes, and then 
subjected to Exonuclease HI and Mung Bean deletion analysis according to manufacturer's 
(Stratagene) instructions. Briefly, 20 ng of plasmid pISM2050.2 were first digested with Pstl 
then Smal. Following a 0 (no enzyme), 1, 2 or 3 min digestion with 20 U Exonuclease III/|J.g 
DNA , the mixture was heated to 68°C and placed on dry ice. Fifteen units of Mung Bean 
nuclease were added to the mixture and incubated for 30 min at 30°C. Following a phenol-
chloroform extraction, the deletion products were ligated and used to transform E. coli DH5a. 
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RESULTS 
M, capricolum Promoter trp'-lacZYA Fusion Studies 
Construction of lacZ translational fusions with the M. capricolum rrnA P2 
promoter and P-gal activities 
Initial studies were designed to explore the possibility of using the E. coli lacZ as a 
reporter gene for studying genetic regulation in mycoplasmas. The study examined the ability 
of a defined mycoplasma promoter to generate a translational fusion with the trp'-lacZYA 
operon. Plasmids pISM2004 - 2006 and pISM2009 - 2011 were constructed and transformed 
into Acholeplasma ISM 1520 as described in the Materials and Methods. The resulting 
Acholeplasma recombinants were analyzed for P-gal activity, and the results are shown in 
Figure 1 A. The overall levels of p-gal activity in Acholeplasma were very low in comparison to 
E. coli. The M. capricolum promoter was able to drive the expression of lacZ in both E. coli 
and Acholeplasma ISM 1520. The M. capricolum promoter in the reverse orientation with 
respect to lacZ (pISM2011), however, was not able to generate P-gal activity in either 
Acholeplasma or E. coli. Slightiy higher levels of P-gal activity were generated in 
Acholeplasma with the additional 700 bp region from the M. capricolum rrnB PI promoter 
region in plasmid pISM2010 supporting an earlier observation that the region upstream of the 
promoter influences transcriptional levels (87, 99). 
Analysis of transcript levels 
To examine the relative strengths of each promoter, transcript levels of Acholeplasma 
strains ISM2004, ISM2005, ISM2006, ISM2009, and ISM2010 were measured. Figure IB 
shows that the M. capricolum rrnA P2 promoter (ISM2005 and ISM2010) generated the 
highest transcript levels of the lacZ gene in Acholeplasma. The transcript levels using 
Figure 1. Construction, message levels, and p-galactosidase activities of the trp'-lacZYA 
fusion plasmids.(A) Construction of the trp'-lacZYA fusion plasmids and 
definition of units of P-galactosidase activity are described in the Materials and 
Methods. Single headed arrows show the direction of transcription. Double 
headed arrow and hatched bar denotes the 700 base pair region upstream of the 
M. capricolum rniB P2 promoter. Shaded boxes represent the trp'-lacZYA 
operon (B). Slot blot analysis of the RNA levels from Acholeplasma ISM1499, 
ISM 1520, ISM2004, ISM2005, ISM2006, ISM2009, and ISM2010 probed with 
either 16S rRNA (left) or lacZ -specific (right) gene probe. The values shown on 
the right hand side of the figure represent the counts in a defined volume after 
subtracting background and adjusting for the relative amounts of total RNA 
loaded into each slot. Levels of RNA used were adjusted by first normalizing the 
relative amounts of RNA used in the rRNA slots then similarly adjusting the RNA 
levels in the lacZ slots. Abbreviations: M. capricolum, M. cap', Ampicillin, Ap; 
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the E. coli promoter only (pISM2006) was negligible whereas the addition of the 700 bp M. 
capricolum rrnB PI upstream sequences (1SM2009) did yield detectable, but low levels of the 
lacZ transcript. Surprisingly, the E. coli consensus promoter was unable to drive expression of 
lacZ in Acholeplasma despite close homology in the -10 and -35 sequences (67). Transcript 
levels of ISM2004 were detectable and were probably due to read through from adjacent genes, 
a common problem when using lacZ translational fusion vectors (221, 223). 
Tn4001lac Promoter Probe Studies 
Placement of unique Smal and BamHl RE sites in a 1S256 arm of Tn400I 
In order to construct the Tn4001lac promoter probe transposon, unique RE sites were fust 
placed into one of the IS2J6 arms o{Tn400J. The unique RE sites were then used as insertion 
sites the lacZ gene. This was accomplished in several steps outlined in Figure 2. First, because 
pKS" contains BamHl and Smal RE sites, these sites were removed, generating plasmid 
pISM2046 Figure 2A). The Smal and BamHl RE sites were inserted 28 bases from the distal 
end of the IS25d arm by first cloning one IS256 arm into plasmid pISM2046 (Figure 2B) and 
then using PGR to create the desired mutation (Figure 2C). Because the inverted repeat region 
only spans the first 26 bp of the IS25(5 element (15), it was predicted that the transposase 
would recognize and bind to the modified inverted repeat normally (10,42). 
In order to reduce the size of the Tn400J containing plasmid, and to have the mutated 
Tn4001 eventually reside on a vector that does not possess the BamHl and Smal RE sites, the 
5J-kh Pstl-Sall fragment containing Tn4001 was ligated into plasmid pISM2046, generating 
plasmid pISM2061 (Fig 2D). Subsequent analyses of transformation frequencies using the 
various Tn400J derivatives generated in this study were compared to the frequency obtained 
using plasmid pISM2061. The plasmids carrying the transposon derivatives cannot replicate 
Figure 2. Placement of unique BamHl and Sma\ RE sites in an IS256 arm of transposon 
Tn4001 (A) Removal of BaniHl and Smal RE sites from plasmid pKS" by 
digestion with Xbal and Smal followed by filling in with Klenow fragment of 
DNA polymerase I and ligation to circularize, generating plasmid pISM2046. (B) 
Insertion of the 1.3-kb Pstl-HindUl fragment from plasmid pISMlOOl containing 
IS2J6 into plasmid pISM2046. A 1.3 kb fragment from a Pstl and HindlU digest 
of plasmid pISMlOOl was isolated from a 0.6% agarose gel, purified using 
Geneclean, and ligated into plasmid plSM2046, generating plasmid pISM2048. 
(*) indicates that only the inserts of plasmids pISM2048 and plSM2048.5 are 
shown. (C) The Smal and BamHl RE sites were placed into IS256 using 
oligonucleotide-directed mutagenesis via PGR, generating plasmid pISM2048.5. 
(D) The 5.7 kb Pstl-Sad fragment containing Tn400J was ligated into plasmid 
pISM2046, generating plasmid pISM2061. (E) The mutant IS256 arm was used 
to replace the wild type arm. The 1.3-kb Pstl-Hindlll fragment from plasmid 
pISM2048.5 was inserted into plSM2061, generating plasmid plSM2062 
(Tn4007mod). The double headed arrow spans the region encompassing Tn4001. 
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in mycoplasmas. Thus, the selectable phenotype was generated by transposition of the 
transposon from the plasmid to the chromosome following transformation. 
The mutated 18256 arm was used to replace the wild type arm to generate Tn^OO/mod on 
plasmid pISM2062 (Figure 2E). The mutation was confirmed by sequence analysis. The 
transformation frequency of plasmid pISM2062 was similar to that of plasmid pISM2061 in 
Acholeplasma ISM 1499 (Table 2). This suggested that the inverted repeat functions have not 
been altered by the mutation. 
Removal of the translational stop codons and the construction of Tn400Ilac 
The 3.1-kb promoterless lacZ gene from pMC1871(16) was cloned into the BamHl site 
of plasmid pISM2062 to generate transposon Tn4001.2062lac (Figure 3). Although this 
construct transformed Acholeplasma ISM 1499, blue colonies did not appear on X-gal 
containing media. The lack of P-gal activity was expected because the 18256 sequence (15) 
shows that there are translational stop codons in all three reading frames contained within the 
inverted repeat (shown in bold letters in Figure 3). Thus, translation originating from adjacent 
mycoplasma chromosomal sequences would be terminated prior to lacZ. 
To overcome premature translation termination, the translational stop codons were altered 
by inserting a pair of synthesized complimentary oligonucleotides that replaced the wild type 
18256 inverted repeat region with an inverted repeat region possessing altered stop codons 
(Figure 3). The mutant adapter was designed to alter two or three of the stop codons. The 
mutant adapter was ligated into plasmid pI8M2062 (Figure 3A) following Pstl and BamHl 
digestions to generate transposons Tn4001.2062.2 (two stop codons altered) and 
Tx\4001.2062.3 (all three stop codons altered). This resulted in the loss of 300 bp of 
unnecessary plasmid DNA between the Pstl site of the cloning vector and the end of the IS256 
arm. Alteration of the stop codons was confirmed by sequence analysis (data not shown). 
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Table 2. Transformation frequencies oiTn400I derivatives in Acholeplasma 
Plasmid Tn400I Derivative Tfa % Blue'^ 
pISM2061 wild type 2.0 X 10-6 [1.3] 0 (0/2,796) 
pISM2062 TrAOOI mod 2.2 X 10-6 [1.3] 0 (0/2,963) 
pISM2062 lac 2062 lac 4.0 X 10-7 [2,3] 0 (0/599) 
pISM2062.2 2062.2 2.4 X 10-6 [1,3] 0 (0/573) 
pISM2062.3 2062.3 6.0 X 10-7 [1,4] 0 (0/573) 
pISM2062.2 lac 2062.2 lac 7.1 X 10-7 [2,3] 7.7 (575/7,510) 
pISM2062.2 lac{xQ\) 2062.2 /ac(rev) 9.6 X 10-7 [2,3] 0 (0/1,572) 
pISM2062.3 lac 2062.3 lac 1.0 X 10-7 [2,4] 4.1 (6/146) 
pISM2062.3 tac{xQv) 2062.3 laciiev) 1.2 X 10-8 [2,4] 0 (0/10) 
PISM2065 2065 2.5 X 10-8 [2,4] 8.8 (27/307) 
^ Tf = transformation frequency. The values represent the average of at least three 
experiments. Transformation frequencies were defined as the number of Gm-resistant 
transformants divided by the number of viable cells used in the transformation mixture. The 
data were analyzed by the Student t test to ascertain the effects of plasmid size, transposon size, 
and alteration of the inverted repeat sequence (stop codons) on transformation frequency. The 
standard error of the means = 1.89 x 10'^. Significance group differences are indicated by []. 
Plasmid size had a significant effect on transformation frequency; group 1 is significantly 
different from group 2 (f<0.002). Alteration of the third stop codon also had a significant 
effect on transformation frequency; group 3 is significantly different from group 4 (f <0.001). 
There were no significant differences for the effect of transposon size or alteration of the first 
two stop codons. 
b Numbers in parentheses indicate the total number of blue colonies divided by the total 
number of white colonies. 
Transposons Tn4001.2062.2 and Tn4001.2062.3 were introduced into Acholeplasma 
ISM1499, and the frequencies of transformation (Table 2) indicated that both functioned in 
Acholeplasma. The frequency of transformation of plasmid pISM2062.3 carrying transposon 
Tn400].2062.3 was reduced by 4-fold. 
The Tn4001lac promoter probe transposon was constructed by cloning the 3.1-kb 
promoterless lacZ gene from plasmid pMC1871 into transposons Tn4001.2062.2 and 
Tn4001.2062.3 to generate the corresponding Tn4001.2062.2lac and "1x14001.2062.3lac 
transposon derivatives. In addition, the lacZ was cloned in the reverse orientation to generate 
transposons Tn40012062.2lacircv) and Tn4001.2062.3lac{xe.v). All of these Tn4001lac 
derivatives were able to transform Acholeplasma (Table 2). The transformation frequencies of 
plasmids pISM2062,2/ac and pISM2062.2/ac(rev) were 2- to 3-fold lower than that of the 
control plasmid, pISM2061. The transformation frequencies of plasmids pISM2062.3/ac and 
pISM2062.3/ac(rev) were 20- to 150-fold lower than pISM2061. Analysis of variance using 
the Student's t test showed a significant {P< 0.002) effect of increasing the plasmid size (by the 
addition of the 3.1-kb lacZ fragment) on transformation frequency. Alteration of the codon 
nearest to the BamYil site in the IS256 inverted repeat also significantly (f<0.001) affected 
transformation frequency. There was no a significant difference for the effect of alteration of 
the first two stop codons on transformation frequency. It should be noted that pMBl-based 
plasmids do not replicate in mycoplasmas and only the transposition event can be observed. 
These experiments were unable to distinguish between the uptake of plasmid DNA 
(transformation) and transposition of Tn400/ into the chromosome. Thus, the combination of 
these two events are reported as transformation frequency in Table 2. 
Figure 3. Removal of the translational stop codons from the inverted repeat of an IS256 element and construction of 
Tn4001lac. (A) Plasmid pISM2062 was digested with Pstl and BamHl to liberate the inverted repeat of IS256 
and 300 bp of intervening plasmid sequences. Relevant sequences are shown adjacent to the corresponding 
plasmid map. Bold letters indicate translational stop codons in IS256. Base changes are indicated by outlined 
letters. (B) Complimentary oligonucleotides were annealed by mixing at equal molar ratios, heating to 70°C for 
3 min, and slowly cooling to room temperature. The mutant oligonucleotide adapter was then ligated into the 
Pstl and BamiQ. sites of plasmid pISM2062, generating plasmids pISM2062.2 (two stop codons altered) and 
pISM2062.3 (three stop codons altered). (*) indicates that a 50/50 mixture of that base was used during 
synthesis of the oligonucleotides. (C) The 3.1-kb BamHl fragment containing the promoterless lacZ from 
plasmid pMC1871 was ligated into the BamHl sites of plasmids pISM2062.2 and pISM2062.3 generating 
plasmids pISM2062.2 lac and pISM2062.3 lac, respectively. 
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Analysis of mycoplasmal Lac fusions 
The testing of the Tn4001 constructs and the analysis of p-gal activity was performed 
initially with Acholeplasma ISM 1499. Expression of [3-gal activity was observed with 
transposons Tn4001.2062.2lac and Tn4001.2062.3lac at a frequency of 8 and 4 percent of the 
Acholeplasma transformants, respectively (Table 2). Intensity of blue color on X-gal 
containing media (data not shown) and |3-gal assays with this species showed that the 
transposon had inserted downstream of promoters of varying strengths. Levels of |3-gal 
activity of three independentTn4001.2062.2lac Acholeplasma transformants were 129, 276, 
and 1,020 units and levels of |3-gal activity of three Tn4001.2062.3lac transformants were 89, 
297, and 790 units. The level of p-gal activity measured with each transformant was very 
reproducible varying less than 5% between cultures and experiments. Expression of P-gal 
activity was not observed in constructs in which lacZ was placed in the reverse orientation 
(Table 2). 
To examine the versatility of the Tn4001lac derivative Tn4001.2062.2lac, M. 
gallisepticum was transformed with plasmid pISM2062.2/flc and the transformants plated on 
X-gal-containing media. Approximately 3% of the transformants appeared to be Lac+ based on 
blue colony formation on X-gal-containing media. Levels of p-gal activity of four independent 
transformants giving blue colonies were 37,44, 52, and 102 units. The level of P-gal activity 
of the white colonies was less than 1 unit. 
Construction and use of the Tn400Ilac rescue transposons 
Transposons Tn4001.2064 and Tn4001.2065 are derivatives of Tn4001.2062.2 and 
Tn4001.2062.3, respectively, containing plasmid pISM205 within the \S256 arm of Tn400/. 
Plasmid pISM205 is a 6-kb plasmid that was generated by cloning the 3.1-kb lacZ fragment 
from plasmid pMC1871 into plasmid pKS (Figure 4A). The BamHl site downstream of lacZ 
Figure 4. Construction of promoter probe transposons designed to rescue adjacent 
chromosomal sequences. (A) Plasmid pISM2065 is a derivative of pISM2062.3, 
containing plasmid pISM205 within the IS256 arm of Tn¥00/. Plasmid 
pISM2065 was constructed by digesting plasmid pISM2062.3 with PvuU, 
isolation of the 5.7-kb fragment, circularization with T4 DNA ligase, digestion 
with BamHl, and ligating with BamHl digested plasmid pISM205. (B) The 
rescue system permits the recovery of adjacent chromosomal DNA by first 
digesting the chromosomal DNA with a unique enzyme in the multiple cloning 
site (e. g., Pstl), followed by ligation and transformation in to E. coli. 
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transcription was removed by partial digestion, fill-in, and ligation. Plasmids plSM2064 and 
pISM2065 were constructed by digesting plasmids pISM2062.2 and pISM2062.3, 
respectively, with PvuU, isolation of the 5.7-kb fragment, circularization with T4 DNA ligase, 
digestion with BamHl and ligating with the 5awHI-digested plasmid pISM205. Orientation of 
the fragments in the resulting recombinant plasmid was confirmed by RE analysis, and the 
function of these transposons was confirmed by transformation into Acholeplasma. Plasmid 
pISM2065 transformed ISM 1499 equally as well as plSM2062.3/ûc and pISM2062.3/flc(rev). 
An analysis of variance for the effect of transposon size on transformation frequency showed 
the effect was not significant. Plasmid pISM2064 failed to transform ISM1499 despite 
confirmation by RE analysis that it was constructed properly. 
A transposon rescue system was developed, similar to the Tn917lac rescue system (267), 
as a means of recovering mycoplasma chromosomal sequences containing promoters (Figure 
4). The resulting Tn4001lac derivative, Tn4001.2065, possesses within one of its IS256 arms 
a plasmid capable of replication and selection in E. coli as well as the promoterless lacZ. Thus, 
mycoplasma chromosomal sequences that were able to drive P-gal expression can be recovered 
and cloned in E. coli as illustrated in Figure 4B. The rescued fragment can be sequenced 
directly by using the T3 or reverse primer that recognizes corresponding sequences within 
pKS. To test the functionality of this system, chromosomal DNA was obtained from different 
pISM2065 transformants, digested with PstI, diluted, ligated, and then transformed into E. 
coli. Recombinant plasmids obtained from these experiments contained chromosomal DNA 
sequences that drive P-gal expression in both Acholeplasma and E. coli. The transformation 
frequency by using pISM2065, however, was 2 logs lower than that of using the plasmid 
containing the wild type transposon. 
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Plasmid pISIVI2050 Promoter Probe Vector Studies 
lacZ fusion library construction and analysis 
Because of the relatively low levels of |3-gal activity resulting from the translational fusion 
system described above, a transcriptional lacZ fusion system (16) was examined. This system 
required that the DNA upstream of the truncated lacZ gene possess the translational start 
elements as well as the promoter to generate a p-gal fusion protein. Acholeplasma ISM 1499 
chromosomal DNA and vector pISM2050 (Figure 5) were digested with Sau3Al or BamHl, 
respectively, ligated together, and the ligation mixtures were transformed into E. coli DH5a. 
Approximately 20% of the E. coli transformants demonstrated the blue phenotype. Analysis of 
plasmid preparations from both blue and white colonies showed that all of the blue colonies 
contained mycoplasmal chromosomal DNA inserts while only 20-30% of the white colonies 
had plasmids with inserts. As a result, only plasmids from blue colonies were used for further 
study. Pools of plasmid DNA from five independent colonies were transformed into 
Acholeplasma IS M1520 where integration of the plasmid occurred within plasmid sequences 
previously introduced into the chromosome (132). If mycoplasma transformants from these 
plasmid pools demonstrated P-gal activity based on blue colony formation on X-gal-containing 
media, individual plasmids were used to transform ISM 1520. Only 13 of 140 plasmid 
preparations giving promoter activity in E. coli were also positive for p-gal activity in 
Acholeplasma. 
The thirteen lacZ fusion constructs that demonstrated P-gal activity in ISM 1520 were also 
used to transform ISM 1499 (Table 3). In this experiment, the region of homology for 
integration of the plasmid into the chromosome was the cloned chromosomal fragment. Only 9 
of the 13 fusions were able to transform ISM 1499. Constructs were confirmed by DNA-DNA 
hybridization analysis (data not shown). The lac fusion constructs were transformed into E. 
coli CSH50, a A{lac-pro) genotype, to simplify the interpretation of the P-gal assay data. 
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Figure 5. Construction of the promoter probe vector, pISM2050. The vector was constructed 
by ligating a 3.1-kb BamHl fragment containing the promoterless lacZ from plasmid 
pMC1871 into ihtBamVil site of plasmid pISMI003. The arrow indicates the 
direction of transcription of lacZ. The asterisk denotes the BamWl site that was 
inactivated. Abbreviations: Promoterless lacZ, p- lacZ\ Ampicillin, Ap; Gentainicin, 
Gm; Tetracycline, Tc; and origin of replication, ori. 
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Table 3. Insert size^ and P-gal activity^ of lacZ fusion constructs in Acholeplasma 




Size (kb) ISM1520 ISM 1499 CSH50 
pISM2050 NA 1 NA 1 
pISM2050.1 2.8 17 12 493 
pISM2050.2 0.9 1,428 ND 4,262 
pISM2050.8 1.0 48 ND 2,365 
pISM2050.18 0.9 48 30 76 
pISM2050.19 1.5 375 167 4,112 
pISM2050.25 0.8 211 188 676 
pISM2050.39 1.0 172 196 3,188 
pISM2050.40 1.7 37 70 688 
pISM2050.66 2.0 35 158 434 
pISM2050.69 2.5 131 53 941 
pISM2050.70 2.3 186 138 4,083 
pISM2050.86 2.2 39 ND 1,199 
pISM2050.89 1.0 73 ND 24 
Strain^ 
CSH50 NA NA NA 1 
%289 NA NA NA 5,382 
^ NA = Not applicable 
^ ND = Not done 
'•^E. coli strains CSH50 and %289 were fully induced with isopropyl P-D-
thiogalactopyranoside. 
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Quantitation of Lac activity 
Acholeplasma transformants containing lacZ fusions gave colonies of varying blue 
intensity on X-gal-containing media. Figure 6 shows a mixture of strains ISM2050.1 (very 
weak P-gal activity), ISM2050.2 (strong P-gal activity), and ISM2050 (vector only, no P-gal 
activity), p-gal assays were performed on the lacZ fusion constructs that were introduced into 
ISM 1520, IS M1499, and CSH50 (Table 3). The results showed that levels of p-gal production 
varied by 100-fold between the various lacZ fusion constructs in Acholeplasma. Levels of p-
gal activity generated by integration of the lacZ fusions in either ISM1520 and ISM 1499 were 
similar except with pISM2050.66 and pISM2050.69. Recombinants demonstrating high levels 
of P-gal activity in Acholeplasma did not always generate high levels of activity in E. colL In 
addition, pISM2050.89 generated more p-gal activity in Acholeplasma than in E. coli. Levels 
of p-gal activity of whole cells when the SDS lysis step was omitted were also examined with 
Acholeplasma strains ISM2050, ISM2050.2, ISM2050.25, and ISM2050.70. Their levels of 
P-gal activity were 3, 68, 19, and 27 units, respectively. The cell-free, ISM 1499 cell, and 
ISM 1520 cell controls in all experiments failed to generate any measurable p-gal activity. 
Levels of the lacZ fusion transcripts were also measured for the ISM 1520 strains 
harboring the lacZ fusion plasmids (Figure 7). These results correlated with the results of the 
P-gal assays in that strains demonstrating higher transcript levels generally had higher levels of 
p-gal activity. There were inconsistencies between p-gal and lacZ fusion transcript levels 
observed in Acholeplasma strains ISM2050.18, ISM2050.66, and ISM2050.69. These strains 
demonstrated higher transcript levels than the levels of P-gal assay would have predicted. 
Immunoblot analysis was performed on several rtcombmani Acholeplasma strains to 
demonstrate the production of a P-gal fusion protein (Figure 8). Acholeplasma ISM 1520 
strains with high levels of P-gal activity reacted more strongly with the anti-P-gal monoclonal 
antibody supporting the results of the p-gal assay. 
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Figure 6. Acholeplasma ISM 1520 transfonnants. Appearance of Acholeplasma ISM 1520 
transformant colonies grown on mycoplasma media containing 80 |J.g per ml 5-
bromo-4-chloro-3-indolyl-P-D-galactoside (X-gal). Colonies with large dark centers 
(i.e., blue color) are ISM2050.2, smaller dark centers, 1SM2050.1, and lightest 
center are ISM2050 (vector only). 
Figure 7. Quantitation of lacZ transcript levels of the lacZ fusion vectors in Acholeplasma 
ISM 1520. Slot blot analysis of the rnRNA levels from Acholeplasma ISM 1499, 
IS M1520, ISM2050, ISM2050.1, ISM2050.2, ISM2050.8, ISM2050.18, 
ISM2050.19, ISM2050.25, ISM2050.39, ISM2050.40, ISM2050.66, 
ISM2050.69, ISM2050.70, ISM2050.86, and ISM2050.89 probed with either 
16S rRNA (left) or lacZ -specific (right) gene probe. Plasmid pSP71 was 
included as a negative control. The 3.1 -kb DNA fragment containing lacZ or the 
1.4-kb fragment containing the 16S rRNA gene were used as positive controls. 
The values shown represent the counts in a defined volume after adjusting for the 
relative amounts of total RNA loaded into each slot as described in Figure 1. 
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Figure 8. Immunoblot analysis of the lacZ fusions in Acholeplasma. Proteins were detected 
with a monoclonal antibody to P-galactosidase. Lanes: A, ISM2050; B, ISM2050.70; 
C, ISM2050.69; D, ISM2050.40: E, ISM2050.39; F, ISM2050.25; G, 
ISM2050.19; H, ISM2050.2,1, ISM2050.1; and J, %289, fully induced with 
isopropylthio- p-D-galactoside. 
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Analysis of Acholeplasma ISM1499 Promoters 
Mapping of Acholeplasma IS M1499 promoters by primer extension 
The transcriptional start sites for the promoters driving the expression of the lacZ in the 
fusion plasmids pISM2050.1, pISM2050.2, pISM2050.8, pISM2050.18, pISM2050.25, 
pISM2050.69, and pISM2050.70 were mapped by primer extension. The quality of the RNA 
was examined by first running 5 to 10 |ig of RNA in a 1.2% agarose gel containing 
formaldehyde and then staining the gel with acridine orange. If the bands corresponding to the 
23S rRNA, 16S rRNA and tRNA were sharp the RNA was considered to be free from 
degradation by nucleases and was used for the primer extension reaction. RNA-DNA 
hybridization analysis, using the 16S rRNA as a probe, was also performed to confirm that the 
16S rRNA band was not smeared. 
Initial experiments were conducted with a primer that was 21 bp in length that was reverse 
and complimentary to a region approximately 45 bp upstream of the lacZ fusion point. The Tm 
of the oligonucleotide was determined to be 38.5°C. As a result, initial reactions gave the 
appearance of false-priming due to the appearance of many primer extension products. An 
oligonucleotide of 30 bp (30-mer) was then constructed that has a Tm of 85°C to reduce the 
amount of primer extension products. The use of this 30-mer did reduce the number of 
background bands detected in the reaction. It should be noted that the appearance of false-
priming could be observed if the unbound 32p was not first removed by precipitating the 
primer 3 times with ethanol. 
Preliminary studies showed that the primer extension product signals were weak for aU 
reactions excepts for those involving ISM2050.2. Because ISM2050.2 generated the highest 
level of lacZ fusion transcript (Figure 7), it was reasoned that the primer extension signal could 
be increased by increasing the amount of target transcript. Thus, the effects of increasing the 
total RNA up to 100 |j,g per reaction was examined. Reactions that used more than 50 |ig of 
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total RNA either did not generated any bands or yielded high levels of background as 
demonstrated by the appearance of many distinct bands. The reactions that failed to generate 
any primer extension products were probably due to the inability to completely resuspend 100 
|ig of RNA in 10 p,l of H2O. Thirty to fifty micrograms of total RNA were found to be optimal 
for the reaction. 
The transcriptional start site for the promoter driving the expression of lacZ in 
pISM2050.8 is shown in Figure 9. Each primer extension product was run adjacent to a 
sequencing ladder generated by using the sequencing primer with plasmid pISM2083 
(containing the insert of pISM2050.2 and the adjacent 800 bp of the lacZ ). The transcriptional 
start site was determined by first counting the number of bases between the lacZ fusion point 
on the ladder to the primer extension product. The number of bases was then compared to the 
sequence of the pISM2050.8 insert-/acZ fusion region. All promoters were mapped in this 
manner except for the promoter contained within the pISM2050.2 insert. This promoter was 
mapped by directly comparing the primer extension product with the pISM2050.2 insert-/acZ 
fusion sequence contained in pISM2083. 
Exo/Mung deletion analysis of plasmid pISM2050.2 
Plasmid pISM2050.2, which has a 900-bp chromosomal DNA fragment from ISM 1499, 
was shown to generate high levels of P-gal activity when introduced into Acholeplasma 
ISM1520 (Table 3). Exo/Mung deletion analysis was performed on plasmid pISM2050.2 to 
determine the minimum upstream region required to drive the expression of lacZ. Following 
exonuclease HI and Mung Bean nuclease digestion, the products were ligated and used to 
transform E. coli DH5a. Both blue and white colonies were obtained from the 3 min 
Exonuclease III reaction mixture. Five blue and five white colonies were selected and plasmid 
DNAs prepared. Restriction enzyme analysis showed that the blue colonies possessed plasmids 
that were larger than those from the white colonies. Plasmid DNA was prepared with five of 
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Figure 9. Primer extension analysis of the transcriptional start site of the lacZ fusion transcript 
of ISM2050.8 . The primer extension product (indicated by the arrow) was run 
against a sequencing ladder generated widi pISM2083. Lanes G = guanine, A = 
adenine, T = thymine, C = cytosine, and 1 = the primer extension product from 
ISM2050.8. 
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these clones and the DNA was used to transform ISM1520. Acholeplasma ISM1520 
transformed with piasmid pISM2075 demonstrated no |5-gal activity by either a blue phenotype 
on X-gal-containing media or by P-gal assay. Transformants possessing the other plasmids 
demonstrated blue colony formation on X-gal containing media and p-gal assay. The levels of 
P-gal activity of these transformants ranged from 861 to 1,080 units. All of the plasmids in the 
transformants generating the Lac+ phenotype mapped to within 100 bp of each other (Figure 
10). The deletion of the Lac" transformant included the entire 900-bp insert as well as part of 
the lacZ. The mutation endpoints were mapped by sequence analysis. The sequence 
downstream of the mutation endpoints represent the insert DNA remaining following the 
Exonuclease IE/ Mung Bean digestions. The transformants generated by using the deletion 
plasmids from the 0, 1, and 2 min Exonuclease IH digestions all gave the Lac+ phenotype on 
X-gal-containing media. 
Preliminary determination of an Acholeplasma ISM1499 consensus promoter 
sequence 
The transcriptional start sites and upstream regions the lacZ fusion transcripts for seven of 
the ISM2050 derivatives are shown in Table 4. The upstream regions were aligned at the 
putative sequences encompassing the -10 and -35 promoter regions. The regions were defined 
based on their similarity to the E. coli consensus promoter (84). A consensus promoter 
sequence was derived based upon the frequency with which a particular base appeared in the 
same position in the -10 and -35 regions. Also shown in Table 4 are the putative -10 and -35 
regions reported for the M. pnuemoniae PI operon (95), M. capricolum rniA P2, rniBl (160) 
and the E. coli consensus promoters. The average number of bases that align between the 
IS M1499 promoter regions and the E. coli consensus promoter regions are 4.4 bp for the -10 
region and 3 bp for the -35 region. Moreover, the spatial relationships between the 
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Figure 10. Exo/Mung deletion analysis of the ISM 1499 chromosomal DNA region of 
ISM2050.2. Arrows indicate the point where deletion ends. The sequence to the 
right of the arrows represent the downstream region remaining. The bases to the left 
of the arrows have been deleted for each plasmid. The putative -35 and -10 regions 
of the promoter, ribosomal binding site, translational start site, chromosomal DNA 
-lacZ fusion point {Sau3Al site) are underlined. An asterisk indicates the 
translational start site. The lacZ region is denoted in bold. 
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Table 4. Alignment and determination of the putative -10 and -35 promoter regions of the 



























TtcAtn 16 to 18 bp TATAaW 6 to 8 bp 
TTGCTG 10 bp TAAACT 5 or 6 bp 
TTGAAA 17 bp TATACT 7 or 8 bp 
TTAAAA 18 bp TAGAAT 7 or 8 bp 
TTGACW 16 to 18 bp TAtAaT 6 to 8 bp 
^The sequences of the upstream regions of lacZ fusion constructs are aligned to the 
putative -10 and -35 regions based on their similarity to the consensus E. coli promoter 
sequence. Bold letters indicate transcriptional start sites. A = adenine, C = cytosine, G = 
guanine, and T = thymine. 
''Consensus sequence of the promoters driving the expression of lacZ in the pISM2050 
fusion derivatives. Upper case letters in the consensus sequence denote that at least 5 of the 7 
sequences contained that base in that position. Lower case letters indicate that at least 3 of the 7 
sequences contained that base in that position. W = A or T, n = any base. 
Table 4. (continued) 
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"-The sequence for the M. pneumoniae PI operon promoter was reported by Inamine et ai. 
(95). 
•^The sequences for the M. capricolum mi A P2 and irnBl promoters were reported by 
Muto et al. (160). 
®The sequence for the E. coli consensus promoter was reported Hawley and McClure 
(84). 
transcriptional start and the -10 region as well as between the -10 region and the -35 region 
were similar to the E. coli consensus promoter. 
The acholeplasma consensus -10 and -35 promoter regions were also similar to the M. 
pneumoniae PI, M. capricolum rniA P2 and rrnBl promoters. The distance between the -35 




The ability to examine gene regulation of mycoplasmas has been hampered by the lack of a 
suitable genetic system to adequately assess the influence of their gene regulatory elements (67, 
170). Because of the alternative codon usage (94, 265) and the potential differences between 
regulatory proteins of mycoplasmas and other bacterial cloning hosts, it is important that 
mycoplasma gene regulation be studied in its natural host. This laboratory has shown that the 
transposon Tn4001 will transpose from suicide delivery vectors to the chromosome of 
mycoplasmas (133). In addition, a plasmid-based cloning system which relies on the ability to 
introduce foreign DNA into the chromosome via homologous recombination with plasmid 
sequences previously introduced into the chromosome was developed in this laboratory (132, 
134). Thus, the aims of the studies reported in this dissertation were to expand the 
mycoplasmal cloning systems developed in this laboratory to include a useful reporter gene for 
the examination of mycoplasma gene regulatory elements in vivo. Once the promoter probe 
vectors were developed, their ability to locate mycoplasma promoters was examined. 
M. capricolum Promoter trp'-lacZYA Fusion Studies 
Because the E. coli lacZ gene has been shown to be an effective reporter gene in other 
heterologous bacterial backgrounds (9, 113,229,268), initial studies were designed to 
examine whether lacZ could also be used as a reporter gene in mycoplasmas using defined 
promoters to drive the expression of a trp'-lacZ operon fusion. The generation of high levels of 
P-gal in E. coli using the M. capricolum rrnA P2 promoter showed that the E. coli RNA 
polymerase recognized M. capricolum promoter sequences. In contrast, the E. coli rniB PI 
promoter was not recognized by the Acholeplasma RNA polymerase as evidenced by the lack 
of mRNA produced (Figure IB). Although the -35 and -10 regions of these promoters were 
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similar (67, 87), the Acholeplasma RNA polymerase was more stringent supporting previous 
studies using in vitro transcription assays (87). 
Low levels of P-gal activity in Acholeplasma were observed using the M. capricolum 
promoter in a trp'-lacZ operon fusion (Figure 1 A). This could be accounted for, in part, by the 
single copy insertion into the chromosome or by poor recognition of the M. capricolum 
promoter by the Acholeplasma RNA polymerase. A more likely explanation, however, is that 
the translation initiation region of the E. coli trp gene promoter was not efficiently recognized in 
Acholeplasma. The trp'-lacZ mRNA transcript levels in ISM2005 and ISM2010 are relatively 
high (Figure IB) despite the low levels of P-gal being produced (Figure I A). 16S rRNA 
sequence homology suggests that mollicutes are more closely related to Gram-positive 
organisms than Gram-negative organisms (257). Thus, the differences in translational 
specificity that has been demonstrated between the Gram-negative and Gram-positive bacteria 
(81) appears to include mycoplasmas as well. It was clear from these initial studies, however, 
that lacZ could be used as a reporter gene in mycoplasmas. 
Tn400Ilac Promoter Probe Studies 
The primary goal of these studies was to develop a transposon-based promoter probe 
vector for use in mycoplasmas. Because our laboratory had previously shown that Tn4001 
could be introduced into mycoplasmas from a plasmid delivery vector (133), a study was 
undertaken to develop a Tn4001lac promoter probe transposon. In addition, a means of 
rescuing the promoter-containing sequences in the mycoplasma chromosome that drive the 
expression of the lacZ in the transposon was pursued. 
The construction of the Tn4001lac promoter probe vector was initiated by inserting unique 
BamHl and Smal RE sites into an 18256 arm ofTn4001, and then inserting the lacZ gene into 
one of these RE sites. The location of these RE sites in the IS2J6 element ofTa4001 was an 
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important consideration. The right and left \S256 elements were shown to possess identical 
1,324-bp sequences (15). Therefore, the probability that only one of the arms encodes the 
functional transposase, as shown with Tn5 (208), was unlikely. The IS2J6 element has 26-bp 
terminal inverted repeats in which 17 bp match. In order to avoid interrupting the terminal 
inverted repeats, the BamHl and Sntal RE sites were placed 28 bp from the end of the 1S256 
element to generate plasmid pISM2062 (Figure 2). 
The insertion of the BamHl and Smal RE sites, however, could have affected the 
transposition activity of Tn400I as a consequence of interrupting the promoter for the 
transposase. The mutation resulted in the insertion of an additional 11 bp between the -10 and 
-35 region of the predicted transposase promoter (15). There are two possible reasons that 
transformation frequency was not affected by the mutation. First, the change in the spatial 
relationship between the -10 and -35 region was tolerated and transcription still proceeded. 
This is unlikely, however, because it has been shown that changing the distance between the 
-10 and -35 region affects promoter strength (84). The second explanation is that the 
transposase produced from the unaltered 1S256 element was able to provide the necessary 
transposition capabilities. It has been shown in Tn5 and TnJO that the transposase was able to 
complement in cis when the inverted repeat regions were relatively close to the transposase 
gene (152, 174). 
The 3.1-kb lacZ fragment was inserted into pISM2062 to generate plasmid plSM2062/ac. 
Although this construct could transform Acholeplasma ISM1499, no blue colonies appeared on 
X-gal-containing media. This was not unexpected because examination of the sequence 
between the end of the IS256 element and the lacZ fragment showed translational stop codons 
in all three reading frames (Figure 3) (15). Alteration of the stop codon nearest to the BamHl 
RE site resulted in a significant (f<0.001) decrease in transformation frequency as compared to 
the wild type (Table 2). There was not a significant effect of altering the other two codons as 
compared to the wild type. 
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The decrease in transformation frequency as a result of altering the codon nearest to the 
BamYil RE site may be explained in two ways. First, the site around this stop codon has the 
greatest base homology between the inside and outside terminal inverted repeat regions 
suggesting that this site may be involved in transposase binding or recognition. Byrne et al. 
(15) have postulated that the transposase may recognize sequences common to both of the 
terminal inverted repeat regions. Second, this stop codon also lies within the predicted -35 
region of the transposase (15). Thus, the reduction in transposition as measured by its effect on 
transformation frequency could either be a result of altering the transposase binding site or 
decreasing the promoter strength of the transposase. 
The addition of the 3.1-kb lacZ gene to plasmids pISM2062, pISM2062.2, or 
pISM2062.3 (generating plasmids pISM2062/ac, pISM2062.2/ac and pISM2062.3/flc) also 
resulted in a significant (f<0.002) decrease (3- to 7-fold) in transformation frequency. This 
could have been due to an increase in plasmid size, or the placement of the lacZ gene in the 
IS25Ô arm could have affected stability of the transposon. In a previous study with an 
integrative plasmid system in mycoplasmas (134), it was shown that larger plasmids have 
lower transformation frequencies than smaller plasmids. 
In addition, Byrne et al. (15) have described a region of dyad symmetry encompassing the 
transposase promoter and ribosomal binding site able to form a stem-loop structure. Placement 
of the lacZ gene into the IS256 arm would have either eliminated the formation of the stem-loop 
structure or would have reduced its stability. The formation of the stem-loop structure is 
thought to be involved in protecting the transposon from the influence of adjacent active 
promoter sequences (15, 38, 112). The decreased transformation frequencies resulting from 
the placement of the lacZ fragment into the IS256 element may suggest that the stem-loop 
structure has a role in stabilizing the transposon in the chromosome. 
The effects of increased plasmid size and altering the codon nearest to the BarnWl site 
appear to be independent. The additive effect of the modification of the third stop codon and the 
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increase in plasmid size is exemplified by the 50- to 100-fold difference in transformation 
frequencies between plasmids pISM2061, pISM2062, or pISM2062.2 and pISM2062.3/flc, 
pISM2062.3/ac(rev), or pISM2065 (Table 2). The insertion of lacZ or the altering of the third 
stop codon only resulted in a 5- to 10-fold decrease in transformation frequency. 
A Student's t test was conducted to examine for significant effects of transposon size on 
transformation frequency. This was done by comparing the transformation frequencies 
between pISM2065 and pISM2062.3/ac and pISM2062.3/flc(rev). All three of these plasmids 
possess an 18256 element with all three stop codons altered and are similar in size. However, 
pISM2065 has the 3-kb plasmid inserted into the IS256 arm. The results showed that 
transposon size did not significantly affect transformation frequency. 
P-galactosidase activity was observed in 7.7, 4.1, and 8.8 percent of the Acholeplasma 
ISM 1499 transformants with transposons Tn4001.2062.2lac and Tn4001.20623lac, and 
Tn40012065, respectively (Table 2). Blue color on X-gal-containing media (data not shown) 
and P-gal assays indicated that the transposons had inserted in regions of active transcription in 
the chromosome. Varying levels of P-gal activity were measured, however. This indicated that 
either the transposon had inserted downstream of promoters of varying strengths, the stability 
of the lacZ fusion transcript differed, or stability of the protein was altered. P-galactosidase 
activity was not observed in constructs in which lacZ was placed in the reverse orientation 
showing that the promoters driving the expression of lacZ lie outside the transposon. The 
versatility of the Tn400Ilac was tested by using plasmid pISM2062.2/ac to transform M. 
gallisepticum. The recovery of Lac+ transformants demonstrate that this transposon would be 
effective in locating promoters of other species of mycoplasmas. 
Another aim of these studies was to develop a means of rescuing sequences adjacent to the 
transposon that are driving the expression of lacZ contained in the transposon. A transposon 
rescue system modeled after the Tn917lac rescue system developed by Youngman et al. (267) 
was developed with Tn400I (Figure 4). The resulting Tn4001lac derivative, Tn4001.2065, 
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possesses within one of its IS256 arms a plasmid capable of replication and selection in E. coli 
as well as the promoterless lacZ. Thus, mycoplasma chromosomal sequences that are able to 
drive P-gal expression can be recovered and cloned in E. coli as illustrated in Figure 4B. 
Acholeplasma chromosomal sequences have been successfully rescued using this system. 
Plasmid pISM2065 has a major drawback in that it transforms Acholeplasma IS M1499 at 
a very low frequency (10"* transformants/CFU) probably due to the altered third stop codon. 
Therefore, only 10 to 50 transformants can be expected to be recovered per transformation. 
Unfortunately, plasmid pISM2064 did not transform ISM 1499. Based upon the transformation 
frequency results with its parent plasmid pISM2062.2, a 10-fold increase in transformation 
frequency would have been expected with pISM2064. Plasmids pISM2064 and pISM2065 
have identical RE patterns, yet pISM2064 was not functional. The inability to transform 
ISM1499 with plasmid pISM2064 cannot be explained at this time. 
In summary, a Tn4001lac promoter probe vector for use in mycoplasmas has been 
developed. Placement of the BwwHI and Smal RE sites into the IS25d arm ofTn400I did not 
effect transformation frequency. Removal of all three stop codons and increasing the plasmid 
size appeared to reduce the transformation frequency. Nevertheless, these Tn4001lac 
derivatives are suitable for the detection and analysis of mycoplasma promoters and/or 
translational start elements in vivo. Moreover, the ability to rescue adjacent chromosomal 
sequences driving the expression of lacZ using transposon Tn4001.2065 should facilitate the 
rapid analysis of mycoplasma regulatory sequences. 
Plasmid pISM2050 Promoter Probe Studies 
Construction and use of the plasmid promoter probe vector pISM2050 
A transcriptional fusion vector was constructed (Figure 5) in hopes of increasing [3-gal 
activity. This vector required both the transcriptional and translational sequences cloned 
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upstream of the promoterless lacZ for the expression of P-gal. Thus, unlike the M. capricolum 
studies described above, both the transcriptional and translational start regions were from 
Acholeplasma. A library of cloned fragments was produced and screened in E. coli prior to 
introduction into Acholeplasma because of the large quantities of plasmid DNA (7 to 10 |ig) 
required for transformation into mycoplasmas (134). Interestingly, only 10% of the 
recombinants that demonstrated promoter activity in E. coli also showed activity in IS M1520. 
This may be explained in two ways. First, pooled plasmid preparations were used to initially 
transform ISM1520, and it is possible that in some of the pooled preparations, promoter-
containing constructs were under represented, did not transform, and thus, all transformed 
colonies would appear to have the Lac phenotype. In an attempt to prevent this, it was 
assumed that each plasmid of the pool would be represented in the transformed colonies if 
more than 50 transformants arose from the plasmid mixture. Second, the A + T-rich 
mycoplasma chromosome may have generated pseudo-promoter activity in E. coli. This is 
supported by similar studies in another A + T-rich organism, S. pneumoniae. Chen and 
Morrison observed more strong promoter-acting sequences with randomly cloned S. 
pneumoniae DNA fragments in E. coli than with randomly cloned E. coli DNA fragments (27). 
It is clear from these studies that random mycoplasma sequences can result in false promoter 
activity in E. coli thereby demonstrating the importance of examining gene regulation in the 
original mycoplasma host 
The lacZ fusion constructs were introduced into two difierent Acholeplasma chromosomal 
locations to examine whether location would affect [3-gal activity levels. Integration was 
targeted to a single chromosomal site in ISM 1520 or to the original location of the cloned 
fragment in ISM1499. The levels of P-gal activity were similar whether the plasmid constructs 
were introduced into ISM 1520 or into ISM 1499 except for plasmids pISM2050.66 and 
pISM2050.69 (Table 3). The 3- to 5-fold change in levels of P-gal activity in these constructs 
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suggests that chromosomal location may influence gene expression. The inability to transform 
ISM 1499 with plasmids pISM2050.2, pISM2050.8, pISM2050.86, and pISM2050.89 despite 
repeated attempts, suggests that the integration of these plasmids into the chromosome at their 
normal location may be lethal. 
The difference in levels of P-gal between Acholeplasma and E. coli may be due to the lacZ 
fusion construct copy number. In E. coli, the fusion construct exists as a high copy number 
plasmid while in Acholeplasma the plasmid is integrated into the chromosome. The higher 
levels of P-gal activity generated by the integration of plasmid pISM2050.89 in Acholeplasma 
than in E. coli was unexpected. This may suggest that there is more than one class of 
promoters in mycoplasmas. Hudson and Stewart (90) have isolated 2 classes of S. aureus 
promoters; one that directs chloramphenicol acetyltransferase expression in both E. coli and S. 
aureus, and another that only directs expression in Gram positive hosts. Their results suggest 
that there is something unique about this second class of Gram positive bacterial promoters 
such as the need for a regulatory factor or recognition by a specific class of sigma factors of the 
RNA polymerase. 
Transcript levels of the lacZ fusion products from the Acholeplasma IS M1520 strains 
transformed with the pISM2050 derivatives were measured and compared to levels of P-gal 
activity. Generally, strains demonstrating higher levels of P-gal activity (Table 3) also had 
higher transcript levels (Figure 7). There were some exceptions, however. Strains 
ISM2050.18, ISM2050.66, and 1SM2050.69 had relatively low levels of P-gal activity 
compared to the relative level of transcript measured. This indicated that either the lacZ message 
in these strains was unstable or the message was not efficiently translated. 
Analysis of Acholeplasma ISM1499 promoters 
The primer extension studies (Figure 9) showed that indeed the Acholeplasma ISM 1499 
chromosomal sequences adjacent to lacZ in the plasmid derivatives of pISM2050 contained the 
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promoters that were driving the expression of lacZ. Unfortunately, 6 of the 13 promoters could 
not be mapped. The promoters driving the expression of lacZ contained in 1SM2050.19 and 
ISM2050.40 probably could not be mapped because of the low amount of lacZ fusion 
transcript produced in these strains (Figure 7). The reason(s) that the other transcriptional start 
sites could not be determined remains an enigma at this time. One possible reason is that the 
transcriptional start is too far upstream from the point in which the primer binds the message. 
Reverse transcriptase has a tendency to pause or stop in regions of high secondary structure 
and the enzyme is the most efficient when the 5' end of the mRNA is within 100 bp of the 
primer target region (213). 
Exonuclease ni/Mung Bean nuclease deletion analysis of the promoter driving lacZ 
expression in ISM2050.2 (Figure 10) supported the primer extension mapping studies in that 
the translational start mapped within the sequences deleted in pISM2075 (Lac) and present in 
pISM2076 (Lac+). Unfortunately, there were not any deletion mutations that ended between 
these two constructs to precisely confirm the minimal upstream distance required for 
transcriptional activity. 
The sequences upstream of the transcriptional start sites were aligned (Table 4). The -10 
and -35 regions were assigned based upon their similarity to the E. coli consensus sequence as 
reported by Hawley and McClure (84). Defining a mycoplasma promoter by its similarity to the 
E. coli consensus promoter could be misleading because mycoplasma DNA, like E. coli 
promoters, is A + T-rich. Therefore, it is especially important with mycoplasma promoters to 
correlate the sequence data with promoter mapping studies. 
Alignment of the sequences upstream of the mapped transcriptional start sites suggested 
that the -10 regions were similar to the -10 region of the E. coli consensus promoter, but the 
-35 regions were more variable. The average of 4.4 bp conserved at the -10 region is similar to 
the 4.2 bp conservation observed with the E. coli and phage promoters examined by Hawley 
and McClure (84). There was only a 3 bp conservation at the -35 region of the acholeplasma 
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promoters which is about 1 bp less than the 3.9 bp observed with the E. coli and phage 
promoters. The observation that the -10 region was more like the E. coli consensus promoter 
than the -35 region is consistent with previous reports examining the putative mycoplasma 
promoter regions (29, 30, 95, 160). 
The result that the Acholeplasma promoters were similar to the E. coli consensus promoter 
is not unexpected because the lacZ fusion constructs were initially screened in E. coli for their 
ability to give the Lac+ phenotype. Thus, only the Acholeplasma upstream regions that are 
recognized by E. coli RNA polymerase were considered for future analysis in Acholeplasma. 
The putative -10 and -35 regions were also similar to the E. coli consensus promoter 
region with respect to distance from the transcriptional start site (6 to 8 bp) and the intervening 
distance between the regions (16 to 18 bp). The Acholeplasma promoter sequence was 
different from the putative M. pneumoniae PI promoter (95) with respect to the distance 
between the -10 and -35 regions (Table 4). The shorter intervening distance suggests that the 
PI gene promoter may be regulated differently; perhaps the promoter is recognized by a 
different sigma factor. In E. coli, the genes that respond to nitrogen starvation possess 
promoters in which the intervening distance is only 6 bp and are recognized by the rpoN gene 
(formally ntrA) product, a^O (gg). 
Should mycoplasma promoter regions be defined by their similarity to the E. coli 
consensus sequence? Just because all mycoplasma promoters have been defined in this manner 
(160), does not validate this approach. It could be argued that if the parameters for locating a 
promoter region are limited to their similarity to the E. coli consensus sequence, then naturally 
only E. coli consensus-like sequences will be assigned as promoter regions. 
The studies described above demonstrate that Acholeplasma promoter-containing DNA 
have E. co/z-like promoter regions that may or may not function as RNA polymerase 
recognition sequences in Acholeplasma. Additional studies involving fine structure mapping, 
deletion analysis, and site-directed mutagenesis will be required to answer this question. The 
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ideal method in which to define a mycoplasma consensus promoter would be to align many 
upstream regions by their confirmed translational start sites and correlate that information with 
the fine structure mapping studies. Unfortunately, only a few mycoplasma transcriptional start 
sites have been actually mapped. Thus, as more mycoplasma upstream regions are confirmed, 
an analysis for a "true" consensus mycoplasma promoter sequence should be undertaken. 
Summary of the plasmid pISM2050 promoter probe vector studies 
In summary, these data demonstrate the need to be able to examine mycoplasma gene 
regulation in a homologous system. Clearly, E. coli was less stringent in its promoter 
recognition sequences than Acholeplasma, and therefore the use of E. coli in studying 
mycoplasmal promoter structure and function should be limited to an initial screening. These 
studies also showed that the promoter probe vector, pISM2050, can identify cloned 
mycoplasmal chromosomal fragments containing transcriptional and translational control 
sequences. The levels of gene expression from cloned fragments vary by 100-fold indicating 
that gene regulation is occurring at the transcriptional and/or translational level in 
Acholeplasma. Immunoblot analysis (Figure 8), measurement of message levels (Figure 7), 
and the intensity of blue color on X-gal-containing media (Figure 6) confirm this conclusion. 
Primer extension studies showed that the promoter driving the expression of lacZ was from 
acholeplasma. Moreover, the putative promoter regions resemble the E. coli consensus 
promoter at the -10 region but were more variable at the -35 region. 
Summary 
The integrative plasmid system lends itself to analysis of gene regulatory elements in 
mycoplasmas by offering the ability to identify gene regulatory elements, to introduce defined 
mutations in promoter sequences, and has the potential to identify and study transcriptional 
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regulators. These studies showed that lacZ could be used as a reporter gene in mycoplasmas. 
These studies also demonstrated the need to be able to examine mycoplasma gene regulation in 
its natural host, the mycoplasma, because of the pseudo-promoter activity in E. coli. In 
addition, mycoplasmas regulate levels of gene expression because differing levels of P-gal 
activity were generated between the various lacZ fusion constructs. The transposon studies 
showed that Tn4001lac could integrate and detect sites of active transcription in both 
Acholeplasma and Mycoplasma. Thus, this vector should be useful for the detection of 
promoters for a variety of different mycoplasmas. Finally, the regions upstream of 7 
transcriptional start sites were sequenced, and the putative promoters were determined. The -10 
regions oi Acholeplasma promoters were similar to the -10 region of the E. coli consensus 
promoter. The putative -35 regions of the Acholeplasma promoters were more variable. 
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APPENDIX A: SEQUENCES UPSTREAM OF LACZ IN THE pISM2050 FUSION 
PLASMIDS 
118 
Frame 2 Pro Val UKN Leu UKN Leu Ser Met Lys Asn Ser Gin lie Leu Val Lys UKN 
CCA GTG GNC CTC ATN CTG AGT ATG AAA AAC TCC CAA ATC TTG GTC AAG NAG 
10 19 28 37 46 
Val UKN Tyr Tyr TER Tyr Leu Thr Leu Pro UKN Leu Asn Lys Lys Val TER UKN Asn 
GTA CNT TAT TAT TAG TAT CTG ACT CTA CCA ATN CTG AAC AAG AAG GTT TGA NTC AAT 
61 70 79 88 97 106 
Leu Asn Leu Lys Leu Val Asn Pro Leu Thr Asn Ser Ser Gin Glu Phe Gin Asp Val 
CTG AAT CTA AAG TTG GTA AAT CCA TTA ACG AAC TCT TCA CAA GAA TTC CAG GAC GTA 
118 127 136 145 154 163 
Leu Leu Leu Gin Pro Leu His Pro Thr Cys Ile Glu Phe Asn Lys Leu Leu Lys His 
TTA TTA TTG CAA CCT TTG CAT CCA ACT TGT ATC GAA TTC AAC AAA TTA TTG AAG CAT 
175 184 193 202 211 220 
Leu Asn TER Gin Val Glu Lys Leu Leu Phe Leu Asp Val Leu Trp Asn Val Leu Leu 
CTG AAT TAA CAG GTA GAA AAG TTG CTG TTT TTG GAC GTT CTA TGG AAC GTG CTA TTG 
232 241 250 259 268 277 
-35 
Arg Leu Asp Asn Asn Gin Ala Ile Leu Asn Leu Glu Lys Val His Ser Leu His Leu 
AGG CTG GAC AAC AAT CAG GCT ATA TTA AAC CTA GAA AAG GTA CAT TCA CTG CAC CTG 
289 298 307 316 325 334 
-10 * 
Lys Asn Tyr Ile Asn Ile Asn Leu Lys Lys Leu Val Phe Trp Leu Leu Val Pro Lys 
AAG AAC TAC ATA AAT ATA AAC TTG AAS AAA CTT GTA TTT TGG TTA CTG GTT CCC AAG 
346 355 364 373 382 391 
rbs start 
Val Asn His Leu Gin His Tyr Gin Glu Leu Leu Met Asp Pro Val Val 
GTG AAC CAC TTG CAG CAT TAT C^A GAA TTG CTA ATG GAT CCC GTC GTT TT 
403 412 421 430 439 
Figure Al. Sequence upstream of the lacZ gene in pISM2050.1. The lacZ- chromosomal DNA 
fusion is shown in bold (GATC). The putative -35 and -10 promoter regions are 
underlined and the translational start site is indicated by an (*). The potential 
ribosomal binding site (rbs) and translational start site (start) is also underlined. The 
potential ribosomal binding site was determined by aligning the sequence with the 
last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
119 
Frame 3 Val Leu Asp Glu Val Leu Lys His His Arg Tyr Ser Tyr Leu Asn TER Ser 
GTC TTG GAT GAA GTC TTA AAG CAC CAC CGA TAC TCA TAC CTG AAT TAA TCC 
11 20 29 38 47 
His lie Phe Leu Leu Tyr Asn Leu Gin Leu lie TER His Leu Leu His Met Arg lie 
CAT ATT TTC TTG CTT TAT AAC TTG CAG TTG ATA TAA CAC CTC TTG CAT ATG AGG ATT 
62 71 80 89 98 107 
Val Leu Gin Gin Gin Lys Pro Cys Phe TER Gly Lys Val Leu TER Val Ser Arg Met 
GTC CTC CAA CAA CAA AAA CCT TGT TTT TAA GGT AAG GTT CTT TAA GTA TCG CGC ATG 
119 128 137 146 155 164 
Leu Gin Arg Thr His Leu Ser Arg Tyr 
TTG CAA AGA ACG CAT TTA AGT CGA TAT 
176 185 194 
-35 
Leu Ser Ser Phe Asn Tyr Tyr Tyr lie 
TTA TCT TCC TTT AAT TAC TAT TAT ATA 
233 242 251 
rbs start 
Ser Asp Lys Met Ala Gin Asn Lys Thr 
AGT GAT AAG ATG GCA CAA AAT AAG ACA 
290 299 308 
Glu Lys TER Phe TER Pro Phe Phe Ser Ser 
GAA AAA TAA TTT TAG CCG TTT TTT TCA TCA 
203 212 221 
-10 * rbs 
Val TER Tyr Lys Lys Tyr Lys Ile Ile Trp 
GTA TAA TAT AAA AAG TAT AAG ATT ATT TGG 
260 269 278 
Ala Thr Lys Glu Lys Ala Val Lys Pro Ala 
GCA ACA AAA GAA AAG GCA GTA AAG CCT GCT 
317 326 335 
Lys Lys Glu Ser Leu Val Phe Lys Asp Pro Val Val 
AAA AAA GAA TCT TTA GTA TTT AAA GAT CCC GTC GTT TT 
347 356 365 374 
Figure A2. Sequence upstream of the lacZ gene in pISM2050.2. The lacZ- chromosomal DNA 
fusion is shown in bold (GATC). The putative -35 and -10 promoter regions are 
underlined and the translational start site is indicated by an (*). The potential 
ribosomal binding site (rbs) and translational start site (start) is also underlined. The 
potential ribosomal binding site was determined by aligning the sequence with the 
last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
120 
Frame 2 Arg Val Ser Asn lie lie Asn Tyr Val Thr Thr Ser Leu Ala lie Val Lys 
CGA OTA ACT .AAC ATT ATT AAC TAT GTA ACA ACA TCC TTA CCA ATT GTC AAA 
10 19 28 37 46 
Asp Asn Asp Phe Ala lie Val Glu Ser Phe Lys Arg Glu Val Met TER Phe Ile Gin 
GAT AAT GAT TTC GCA ATT GTA GAA TCA TTT AAA CGA GAG GTT ATG TAA TTT ATC CAA 
61 70 79 88 97 106 
Thr Phe Lys Gly lie UKN Val Ser Ser Gly Val Ala lie Pro Lys Ile His His Leu 
ACA TTT AAA GGC ATT GNG GTC TCC AGT GGA GTT GCA ATT CCA AAA ATA CAT CAC TTA 
118 127 136 145 154 163 
Ala Glu Thr Thr Gin Met Ser Leu Lys Lys Phe Ser Thr Asp Lys Asn Val Glu Leu 
GCT GAA ACC ACT CAG ATG AGC TTA AAA AAG TTT TCA ACG GAT AAA AAT GTT GAA CTT 
175 184 193 202 211 220 
-35 
Asn Arg Phe Asn Glu Thr lie Lys Glu Ala Val Ser Gin Leu Glu Leu Leu Thr Leu 
AAT CGT TTT AAT GAA ACG ATT AAA GAA GCT GTT TCT CAA TTA GAA TTA CTT ACG CTA 
232 241 250 259 268 277 
-10 * rbs 
Gin Ser Lys Thr Glu Ile Gly Gin Val His Ala Glu Ile Phe Ser Ala Gin Thr Leu 
CAA TCT AAA ACC GAA ATT GGT CAA GTA CAT GCT GAA ATC TTT AGT GCA CAA ACA CTG 
289 298 307 316 325 334 
start 
Met Leu Lys Asp Pro Val Val 
ATG TTA AAA GAT CCC GTC GTT TT 
346 355 
Figure A3. Sequence upstream of the lacZ gene in pISM2050.8. The lacZ- chromosomal DNA 
fusion is shown in bold (GATC). The putative -35 and -10 promoter regions are 
underlined and the transladonal start site is indicated by an (*). The potential 
ribosomal binding site (rbs) and translational start site (start) is also underlined. The 
potential ribosomal binding site was determined by aligning the sequence with the 
last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
121 
Frame 2 Ser UKN lie Thr Gin Pro lie UKN UKN Glu Val Ser UKN UKN Ser Phe Glu 
AGT AGN ATC ACT CAA CCA ATA ATN NTT GAA GTC TCT NAA NCC AGT TTT GAA 
10 19 28 37 46 
Tyr Val Asn Thr UKN UKN lie UKN UKN Asp Ala Asn lie Pro Arg Gly Ser Phe Tyr 
TAT GTG AAT ACN CNA NAC ATT ATN NAA GAT GCT AAT ATT CCA AGA GGG TCT TTT TAC 
61 70 79 88 97 106 
Gin Tyr Phe Glu Asp Lys UKN Asp Met Tyr Glu Tyr lie Met Asp Tyr lie Ser Ser 
CAG TAC TTT GAA GAT AAG NCG GAT ATG TAT GAA TAT ATC ATG GAT TAT ATT AGT TCA 
118 127 136 145 154 163 
lie Lys Arg Tyr Tyr Phe Lys Ser lie Phe Glu Ala Val Asn Leu Asn Phe lie Glu 
ATA AAA AGA TAT TAT TTT AAA AGT ATA TTT GAA GCA GTG AAT CTG AAT TTT ATA GAG 
175 184 193 202 211 220 
Arg lie Glu Ala lie Tyr Leu Ala Gly Val Lys Phe Lys Ser Glu Asn Pro Asp Phe 
CGA ATA GAG GCA ATT TAT TTA GCG GGT GTA AAA TTT AAG TCC GAG AAC CCT GAT TTT 
232 241 250 259 268 277 
-35 -10 * 
Val Arg Ala Gly Glu Phe Met Leu Lys Ser Pro Leu Tyr Leu Asn Asn Pro Ser Val 
GTA AGA GCA GGA GAA TTC ATG CTT AAA TCA CCT TTA TAT TTA AAT AAT CCA TCA GTA 
289 298 307 316 325 334 
rbs start 
UKN Lys Gly Leu Glu Gin Met lie Ser lie Tyr Glu Ser Trp lie lie Asn Asp Pro 
NCC AAA GGT TTA GAA CAA ATG ATT TCA ATC TAC GAG TCT TGG ATT ATC AAT GAT CCC 
346 355 364 373 382 391 
Figure A4. Sequence upstream of the lacZ gene in pISM2050.18. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The putative -35 and -10 promoter regions 
are underlined and the translational start site is indicated by an (*). The potential 
ribosomal binding site (rbs) and translational start site (start) is also underlined. The 
potential ribosomal binding site was determined by aligning the sequence with the 
last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
122 
Frame 1 Thr UKN UKN Arg UKN Gly Gly UKN Ser Lys Thr UKN UKN Val TER Asn Val 
ACC CNG CNN AGG NCN GGG GGN ANA TCA AAG ACA MGG GNC GTC TAG AAT GTA 
9 18 27 36 45 
TER Arg UKN TER Arg Val Arg TER UKN UKN Leu TER TER Arg Val Cys Ile Tyr Tyr 
TAG AGG AGN TGA AGA GTC AGA TAG TNC TNC TTA TAA TGA AGG GTA TGT ATC TAT TAC 
60 69 78 87 96 105 
UKN Phe Thr Val UKN Pro Tyr Gly Leu Ser Lys UKN Lys Ile Tyr His Gly Phe Lys 
NCC TTT ACA GTT TGN CCG TAC GGA CTT AGT AAA AAN AAA ATC TAT CAT GGA TTT AAA 
117 126 135 144 153 162 
rbs start 
His Leu Lys Thr Arg lie Lys Ile Gly Val Tyr Met Ser His Phe Phe Leu His Phe 
CAC TTA AAA ACT AGA ATT AAG ATT GGA GTT TAT ATG AGT CAT TTC TTT TTA CAT TTT 
174 183 192 201 210 219 
rbs start 
UKN UKN Glu Lys Ser Arg Val Leu Asp Met Glu Glu Val Ile Glu Phe Phe Asp Pro 
NTC NAA GAA AAA TCT AGA GTA CTT CAT ATG GAA GAA GTT ATT GAG TTT TTT GAT CCC 
231 240 249 258 267 276 
Val Val 
GTC GTT TT 
Figure A5. Sequence upstream of the lacZ gene in pISM2050.19. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding site 
was determined by aligning the sequence with the last 15 bp at the 3' end of the 16S 
rRNA gene of A. laidlawii. 
123 
Frame 3 Lys Phe Phe Tyr His Phe Asp Phe Glu Leu Phe Cys Leu Ser lie Ser Leu 
AAG TTT TTT TAT CAC TTT GAC TTT GAA CTC TTC TGC TTG TCT ATT TCA TTG 
11 20 29 38 47 
-35 -10 * rbs start 
Met Tyr Ser Tyr Met lie TER Tyr lie Arg Glu Ser TER Gly lie Gin Met Lys Tyr 
ATG TAT TCA TAC ATG ATA TAA TAT ATA CGC GAA ACT TGA GGA ATA CAA AIS AAA TAC 
62 71 80 89 98 107 
Leu Val Gly Thr Tyr Thr Lys Asn Leu Ser Glu Gly lie Tyr Leu Val Asp Glu Asp 
TTA GTT GGC ACT TAT ACT AAA AAT CTA TCC GAA GGT ATT TAC TTA GTT GAT GAG GAT 
119 128 137 146 155 164 
Lys Val Ser Leu His Met Arg Leu Phe Asn Pro Thr Tyr Phe Thr Leu Gin Glu Gly 
AAA GTC TCT TTA CAT ATG AGA TTA TTT AAT CCA ACT TAT TTT ACT TTA CAA GAA GGT 
176 185 194 203 212 221 
His Leu Phe Thr lie Ala Arg Gly Gly lie Glu Ile Tyr Gin Asp 
CAT TTA TTT ACA ATT GCT AGA GGA GGT ATT GAA ATA TAT CAG GAT C 
233 242 251 260 269 
Figure A6. Sequence upstream of the lacZ gene in pISM2050.25. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The putative -35 and -10 promoter regions 
are underlined and the translational start site is indicated by an (*). The potential 
ribosomal binding site (rbs) and translational start site (start) is also underlined. The 
potential ribosomal binding site was determined by aligning the sequence with the 
last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
124 
Frame 1 Val Cys TER Lys Asp Gin Leu Tyr Met Ser Gly Met Arg Leu Phe Thr Val 
GTC TGC TGA AAG GAC CAG TTA TAT ATG AGT GGG ATG CGT CTG TTC ACG GTA 
9 18 27 36 45 
rbs start 
Gly Gly Leu Gly Glu Asn Gly Gly Asn Met Tyr Val Ile Asp Val Asp Lys Gin Tyr 
GGT GGA TTG GGT GAG AAC GGA GGA AAC ATG TAT GTC ATC GAT GTT GAC AAA CAA TAT 
60 69 78 87 96 105 
rbs 
Phe Ile Leu Asp Ala Gly Val Lys Tyr Pro Thr Gin Ala Leu Tyr Gly Val Asp Glu 
TTT ATT TTG GAT GCT GGT GTA AAG TAT CCC ACT CAA GCA CTC TAT GGA GTC G^T GAA 
117 126 135 144 153 162 
start 
Ile Ile Pro Asn Tyr Arg Met Leu Ile Asn Ile Lys Asp Arg Ile Lys Gly Ile Phe 
ATT ATT CCT AAT TAT AGA ATG TTA ATT AAT ATT AAA GAC CGT ATC AAA GGT ATC TTT 
174 183 192 201 210 219 
Leu Thr His Ala His Glu Asp Pro Val Val Leu Gin Arg Arg Asp Trp Glu Asn Pro 
TTA ACG CAT GCC CAT GAG GAT CCC GTC GTT TTA CAA CGT CGT GAC TGG GAA AAC CCT 
231 240 249 258 267 276 
Gly Val Ala 
GGC GTT GCC C 
288 
Figure Al. Sequence upstream of the lacZ gene in pISM2050.39. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding site 
was determined by aligning the sequence with the last 15 bp at the 3' end of the 16S 
rRNA gene of A. laidlawii. 
125 
Frame 3 Gin Tyr Pro Asn UKN Leu Ser Pro Arg Val Gly Arg Phe lie Asn Ala Gly 
CAA TAC CCA AAC CNC CTC TCC CCG CGC GTT GGC CGA TTC ATT AAT GCA GGT 
11 20 29 38 47 
TER Pro Gly Leu Ser Lys Leu UKN Arg Leu Thr lie Gly Arg Pro Ala Ser Ser Ser 
TAA CCT GGC TTA TCG AAA TTA ATN CGA CTC ACT ATA GGG AGA CCG GCC TCG AGC AGC 
62 71 80 89 98 107 
TER Ser Phe lie Lys Arg Ala Leu Glu Ile Ile Glu Phe His His Glu Lys Tyr Asp 
TGA AGC TTT ATT AAA AGA GCA CTA GAA ATT ATA GAG TTC CAT CAT GAA AAA TAT GAT 
119 128 137 146 155 164 
rbs 
Gly Thr Gly Tyr Pro Lys Gly Leu Lys Gly Glu Asp lie Pro Leu Pro Gly Arg Leu 
GGA ACA GGA TAT CCT AAA GGG TTA AAG GGA GAA GAT ATT CCA TTA CCA GGA AGG TTG 
176 185 194 203 212 221 
start 
Met Ala lie lie Asp Val Phe Asp Ala Leu lie Asn Glu Arg Val Tyr Lys Lys Ala 
ATG GCA ATT ATT GAT GTC TTT GAT GCA CTG ATT AAT GAA AGA GTC TAT AAA AAA GCA 
233 242 251 260 269 278 
Tyr Thr Val Glu Glu Ser Val Lys Ile Ile Lys Glu Asn Ile Gly Lys His Phe Asp 
TAT ACA GTA GAA GAA TCT GTA AAA ATA ATT AAA GAG AAC ATA GGG AAA CAT TTT GAT 
290 299 308 317 326 335 
Pro Val Val 
CCC GTC GTT TT 
347 
Figure A8. Sequence upstream of the lacZ gene in pISM2050.40. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding site 
was determined by aligning the sequence with the last 15 bp at the 3' end of the 16S 
rRNA gene of A. laidlawii. 
126 
Frame 2 Ser Arg Gin Glu UKN Pro TER Lys Arg His Thr lie Ala Leu Leu Asn Val 
TCC CGN CAA GAA TNC CCC TAA AAG CGA CAC ACT ATT GCA CTN CTT AAT GTG 
10 19 28 37 46 
Cys Glu Asn Ser Gin Gly Ser Asn Asp Asp Gly UKN Pro Ser UKN UKN UKN Gly UKN 
TGT GAA AAC TCT CAA GGT TCT AAT GAT GAT GGT GAN CCN AGC NAA NCA TNG GGT GNN 
61 70 79 88 97 106 
Pro He Leu Glu UKN UKN UKN His His Gin UKN Thr UKN Cys UKN UKN Val UKN Val 
CCN ATA CTT GAG ANN CNT AAN CAT CAT CAA NTA ACG NAN TGT NTT NCA GTC GNT GTG 
118 127 136 145 154 163 
Arg Tyr He Gly Gly Met Lys Pro Gly UKN Gly Gly Leu He UKN Ala Tyr Ala Lys 
AGA TAC ATT GGT GGT ATG AAA CCT GGT NCC GGT GGA TTA ATC NGN GCC TAT GCT AAA 
175 184 193 202 211 220 
rbs start? 
Ala Thr Lys Glu Ala UKN Asn Asp UKN UKN Leu Ser UKN Lys Val Thr Gin Thr UKN 
GCA ACC AAA GAA GCG CNA AAT GAT NCC NAA CTC TCT NAA AAG GTC ACT CAA ACC ANN 
232 241 250 259 268 277 
Tyr Glu UKN Val UKN Thr 
TAT GAA GNC GTA NTT ACC 
289 298 
Tyr Glu UKN He Ser Lys 
TAT GAA AAN ATT TCN AAA 
307 316 
He Asp Pro Val Val 
ATT GAT CCC GTC GTT TT 
325 
Figure A9. Sequence upstream of the lacZ gene in pISM2050.66. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding site 
was determined by aligning the sequence with the last 15 bp at the 3' end of the 16S 
rRNA gene of A. laidlawii. 
127 
-35 
Frame 1 Lys Val Val UKN His Lys Met Pro Thr UKN UKN Ala UKN UKN UKN TER Ile 
AAG GTT GTT TNA CAT AAA ATG CCA ACC CNG NAA GCC TNT TNG NAA TAG ATC 
9 18 27 35 45 ' 
-10 * start rbs 
Pro Phe Thr Leu Met Ile TER Tyr Ser Arg Asp Arg TER Val Met Arg Cys Val Lys 
CCG TTT ACA CTC ATG ATA TAA TAT AGT AGS GAT AGA TAA GTG ATG AGG TGT GTG AAG 
60 69 78 87 96 105 
start start start 
Ser Met Ser Val Met Leu Asn Met UKN UKN Asn Lys Glu Ala Leu Ser Met Ala Glu 
TCA ATG AGT GTA ATG CTA AAT ATG CNT NAA AAT AAA GAA GCA CTT AGT ATG GCC GAG 
117 126 135 144 153 162 
Arg Ile Val Leu Asp Tyr Leu Ile Glu Asn Lys Thr Ile Leu Lys Asp Phe Ser Val 
AGA ATT GTT TTA GAT TAC TTG ATA GAA AAT AAG ACA ATC CTG AAG GAT TTT AGT GTT 
174 183 192 201 210 219 
Glu Lys Ile Ala Glu Ala Ala TVr Thr Ser Pro Ala Ser Val Val Arg Met Cys Lys 
GAA AAA ATT GCG GAA GCT GCT TAT ACA TCA CCC GCA TCT GTT GTT AGA ATG TGT AAG 
231 240 249 258 267 276 
Lys Leu Gly Tyr Lys Gly Phe UKN Asp Phe Lys Ile Asp Phe Ile Leu Ala Asn Ser 
AAA CTT GGA TAT AAA GGA TTC NAA GAT TTT AAA ATT GAT TTT ATT TTA GCA AAT TCT 
288 297 306 315 324 333 
Lys Val Glu Ile Pro Glu Thr Ser Glu Tyr Thr Asp Ile Ile Leu Ile Lys Asp Pro 
AAA GTA GAA ATA CCA GAA ACA TCT GAG TAT ACG GAC ATT ATT TTA ATT AAA GAT CCC 
345 354 363 372 381 3 9 0  
Val UKN 
GTC GNT TT 
Figure A10. Sequence upstream of the /acZ gene in pISM2050.69. The /acZ- chromosomal 
DNA fusion is shown in bold (GATC). The putative -35 and -10 promoter 
regions are underlined and the translational start site is indicated by an (*). The 
potential ribosomal binding site (rbs) and translational start site (start) is also 
underlined. The potential ribosomal binding site was determined by aligning the 
sequence with the last 15 bp at the 3' end of the 16S rRNA gene of A. laidlawii. 
128 
Frame 2 Ser TER Ile Lys TER UKN Ile Glu Tyr Gly Ile Ile Tyr TER Cys Ile UKN 
AGC TAG ATT AAG TAA NAT ATA GAA TAT GGT ATA ATT TAT TGA TGT ATA NCC 
10 19 28 37 46 
Gin UKN Asn Leu Tyr Ile Phe Ser Ile Ile UKN Asn Ile Tyr Leu Ile UKN Leu Tyr 
CAA NAC AAT TTA TAT ATT TTT TCA ATC ATT NNA AAT ATA TAT TTA ATA NTG CTT TAT 
61 70 79 88 97 106 
Gly Ile Met Ile Trp UKN UKN Lys TER Asn Ile Lys Gly Ala Trp TER Val Ala Lys 
GGT ATT ATG ATA TGG TNN CNN AAA TAG AAC ATA AAA GGA GCA TGG TAA GTG GCT AAA 
118 127 136 145 154 163 
Leu Asp Gin Thr Lys Thr Pro Phe Phe Asp Lys Ile Arg Ala Tyr Gly Val Ser Gly 
CTC GAT CAA ACA AAA ACC CCA TTT TTT GAT AAA ATT AGA GCA TAT GGA GTC TCA GGA 
175 184 193 202 211 220 
-35 
UKN UKN Ala Leu Asp Val Pro Gly His Lys Leu Gly Ser Ile Asp Asn Glu Phe Thr 
NCG NCG GCT TTA GAT GTT CCT GGT CAT AAA CTG GGT TCG ATT GAT AAT GAA TTT ACA 
232 241 250 259 268 277 
-10 * start 
Arg Tyr Leu Gly His Asn Val Phe Ser Met Asp UKN Asn Ala Pro Arg Gly Leu Asp 
AGA TAT TTA GGA CAT AAÇ GTT TTT TCT ATG GAT NCA AAT GCA CCA AGA GGA CTT GAT 
289 298 307 316 325 334 
Asn Leu Ser Lys Pro Lys Gly Val Ile Lys Glu Ala Gin Ala Leu Ala Ala Asp Ala 
AAT TTA TCN AAA CCT AAA GGT GTC ATT AAG GAA GCA CAA GCA CTC GCA GCA GAT GCT 
346 355 364 373 382 391 
Phe Gly Ala Asp Pro Val UKN 
TTT GGT GCG GAT CCC GTC GNT TT 
403 412 
Figure All. Sequence upstream of the lacZ gene in pISM2050.70. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The putative -35 and -10 promoter 
regions are underlined and the translational start site is indicated by an (*). A 
potential ribosomal binding site was not found. 
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Frame 3 Asp Ser Arg Tyr Arg Val Lys Pro Glu Ile Val Ser His Ser UKN Leu Thr 
GAT AGT CGC TAT AGG GTA AAA CCT GAA ATT GTA TCA CAC AGT NTA TTA ACT 
11 20 29 38 47 
Glu Asp Ala Ile Leu UKN UKN Glu Ala Ser Glu Ile Leu Pro Tyr Ile Thr Asp Asp 
GAG GAT GCG ATA TTA ANT NAA GAA GCA AGT GAG ATA CTG CCA TAT ATT ACA GAT GAT 
62 71 80 89 98 107 
Leu Asp Ala Val Ile Ile Asp Glu Ala Gin Phe Phe Asp Lys Ala Ile Ile Gin Ile 
TTA GAT GCT GTC ATT ATT GAT GAG GCA CAG TTC TTT GAT AAA GCA ATC ATC CAA ATT 
119 128 137 146 155 164 
Ala Asp Asp Leu Ala Asp Arg Gly Leu Arg Val Ile Ile Gly Gly Leu Asp Arg Asp 
GCA GAT GAT TTA GCA GAC CGA GGG CTC AGA GTT ATT ATT GGT GGA CTG GAT AGA GAC 
176 185 194 203 212 221 
Phe Lys Gly Glu Pro Phe Gly Pro Met 
TTT AAA GGT GAA CCT TTT GGT CCA ATG 
233 242 251 
Thr Lys Leu Thr Ala lie Cys Val Lys 
ACT AAA CTT ACT GCA ATC TGT GTT AAA 
290 299 308 
Pro Glu Leu Leu Ala Leu Ala Glu Phe Val 
CCT GAG TTA TTA GCA CTT GCA GAG TTT GTG 
260 269 278 
rbs? start 
Thr Gly Met Pro Ala Thr Arg Thr Gin Arg 
ACA GGA ATG CCA GCA ACC AGA ACC CAA AGA 
317 326 335 
lie lie Asp Gly Lys Pro Ala Ser Tyr Lys Asp Pro Val Val 
ATC ATT GAT GGA AAA CCT GCA AGT TAT AAA GAT CCC GTC GTT TT 
347 356 365 374 
Figure A12. Sequence upstream of the lacZ gene in pISM2050.86. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding 
site was determined by aligning the sequence with the last 15 bp at the 3' end of 
the 16S rRNA gene of A. laidlawii. 
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Frame 3 TER Val Phe UKN Lys Lys Gly UKN Val UKN Leu Thr Phe Tyr UKN Leu Val 
TGA GTA TTT AAN AAA AAG GGG NNA GTG AAN CTG ACT TTT TAC NCT TTG GTG 
11 20 29 38 47 
Glu UKN Gly UKN Ser Leu Ser Leu Glu Glu Glu Ala His Leu Leu Gly Arg Met His 
GAA GNA GGT ATN TCT TTA TCA CTT GAG GAA GAA GCG CAT TTA TTA GGA CGT ATG CAT 
62 71 80 89 98 107 
Ile Ser Pro Tyr UKN UKN Met Phe Ile UKN Lys Asp Glu Asp Leu Ile Ile Gly Ala 
ATA AGT CCT TAT NCA NAA ATG TTT ATC NCA AAA GAC GAG GAT TTA ATT ATT GGG GCG 
119 128 137 146 155 164 
Ala Ser Ile His Thr Ser Thr Lys Pro Arg UKN Lys His Lys Ala Glu Leu Gly Ile 
GCA TCC ATT CAT ACA TCT ACC AAA CCT AGA ANT AAA CAT AAA GCA GAA CTT GGA ATA 
176 185 194 203 212 221 
Ser Val Leu Lys Ser UKN Trp Gly Lys Gly Val Ser Lys Leu Leu Met Asp UKN UKN 
TCT GTT TTA AAG TCA TNC TGG GGT AAA GGT GTA TCT AAG CTA TTA ATG GAT NAA ATN 
233 242 251 260 269 278 
rbs start 
Ile Glu Tyr Ala Lys Thr Ser Gly Phe Ile Glu Met Ile Leu Leu Glu Val Ala Thr 
ATA GAA TAC GCT AAA ACT TCA GGA TTT ATT GAA ATG ATT TTA TTA GAG GTT GCA ACA 
290 299 308 317 326 335 
Thr Asn Thr Arg Ala Ile Lys Phe Tyr Glu Ser Tyr Gly Phe Lys Ser UKN Gly Val 
ACC AAT ACA AGA GCC ATC AAA TTC TAT GAA TCC TAT GGC TTT AAG TCT TNC GGA GTT 
347 356 365 374 383 392 
rbs? start 
Ala Arg Asn Ala Val Lys Met Asp Pro Val Val 
GCN AGA AAT GCA GTA AAA ATG GAT CCC GTC GTT TT 
404 413 422 
Figure A13. Sequence upstream of the lacZ gene in pISM2050.89. The lacZ- chromosomal 
DNA fusion is shown in bold (GATC). The potential ribosomal binding site (rbs) 
and translational start site (start) is underlined. The potential ribosomal binding 
site was determined by aligning the sequence with the last 15 bp at the 3' end of 
the 16S rRNA gene of A. laidlawii. 
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APPENDIX B: IMMUNE RESPONSE OF A FOREIGN GENE 
EXPRESSED IN ACHOLEPLASMA ISMI499 
Rationale and Experimental Design 
The goal of this experiment was to determine whether a foreign gene expressed in 
mycoplasmas could induce a specific immune response. The overall goal of my research has 
been to develop an expression cloning system for use in mycoplasmas. A consensus promoter 
sequence was to be derived from the promoter probe studies and an expression vector for use 
in mycoplasmas was to be generated. Finally, the expression cloning system was to be tested 
by placing a foreign gene downstream of the consensus promoter and determine whether an 
immune response could be induced to that gene upon challenge. Because the promoter probe 
studies showed that the E. coli lacZ was expressed in Acholeplasma, an experiment to 
determine whether mice would mount an immune response to P-galactosidase was conducted. 
Twenty specific pathogen free HE GuJ mice that were 4 months of age were used in the 
study. They were grouped as shown in Table Bl. Following a prebleed, each mouse was 
injected i.p. with 100 p,g of whole cells (killed by repeated freezing and thawing) resuspended 
in incomplete Freund's adjuvant After 7 days, blood was obtained via an orbital puncture. The 
mice were boosted with another 100 |ig of whole cells resuspended in incomplete Freund's 
adjuvant 9 days following the primary challenge. Five days later blood was obtained via an 
orbital puncture. Serum was separated from the RBCs by centrifugation in a microfuge and the 
samples were frozen at -20°C until they were assayed for anti-P-galactosidase activity by 
ELISA. 
The ELISA was performed by first coating a 96-well flat bottom plate with 100 fil of 10 
|Lig/ml P-galactosidase suspended in 0.1 M Na2C03, pH 9.6. Following a blocking step 
overnight with PBS containing 5% BSA, 100 fil of the test serum diluted 1:250 was added to 
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each well. After a 5 h incubation at room temperature, the wells were washed with 0.9% NaCl 
containing 0.05% Tween-20. One hundred microliters of the conjugate, horse radish 
peroxidase labeled goat anti-mouse Ig, diluted 1:1,000 were added to each well. Following a 4 
h incubation at room temperature, 100 |li1 of the TMB substrate was added. The reaction was 
stopped by adding 100 fxl of I M phosphoric acid, and the plate was read with a microtiter plate 
reader at an absorbance of 415 nm. The positive control was a monoclonal antibody to p-
galactosidase diluted 1:100. The negative controls for the ELIS A assay included wells in which 
either no Ag (P-galactosidase), test antisera, or conjugate was added. All samples and controls 
were performed in triplicate. 
Table B1. Experimental design of the Acholeplasma 
challenge study 
Group Sex P-gal activity^ 
PBS 3 F n.a. 
ISM2050.1 5 M 19 
ISM2050.2 4 M 1,193 
ISM2050.70 4 M 201 
ISM2050 4 F 1 
= number of mice. 
^Units of p-gal activity defined as the 
number of monomers of the enzyme per CPU 
generated in one min. (See Materials and 
Methods of dissertation. 
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Results and Discussion 
The results of the ELISA assay are shown in Table B2. The values shown in Table B2 
represent the average absorbance values of the triplicate measurements for each mouse as well 
as the average for all mice within a group. The results show that a low level antibody response 
to P-galactosidase as indicated by absorbance levels was akeady present in these mice and 
introduction of more antigen in the form of a recombinant bacteria did not induce a greater 
antibody response. The ELISA controls worked as expected. The absorbance values of the 
positive control (Mab to P-galactosidase) were not remarkably high but were nevertheless 
positive. There were not any differences in antibody levels between the negative control groups 
(PBS and ISM2050) and the groups (ISM2050.2 and ISM2050.70) that would have been 
predicted to induce the highest levels of antibody response. Moreover, there was not an 
increase in antibody response as a result of the primary and secondary injections of the antigen. 
Because there already appeared to be a low level antibody response to (3-galactosidase, the 
primary and secondary injections should have induced an amnestic response if the |3-
galactosidase protein was being recognized by the mice. P-galactosidase levels (Table 1) were 
determined for these Acholeplasma strains prior to the repeated freezing and thawing process to 
kill the bacteria. Therefore, strains ISM2050.2 and ISM2050.70 were producing relatively 
high levels of P-galactosidase that could have been recognized by the mouse. 
The inability to induce an antibody response was probably due the choice of antigen used 
in this experiment. An existing antibody response to P-galactosidase was not unexpected 
because other bacteria (e. g., E. coli) that the mouse was exposed to produce this enzyme. The 
levels of P-galactosidase introduced with these recombinant strains was probably not high 
enough to induce a higher antibody response. Thus, this experiment suggested that a killed 
Acholeplasma recombinant vaccine was not effective in inducing an immune response to the 
foreign antigen, P-galactosidase. 
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Table B2. Absorbance values of an ELISA examining the antibody 
response to xzcomh\mni Acholeplasmas expressing the 
E. coli lacZ. 
A415 
Group Day 0 Day 7 Day 14 
PBS 0.122 0.119 0.100 
ISM2050.1 0.129 0.134 0.121 
ISM2050.2 0.138 0.133 0.121 
ISM2050.70 0.118 0.106 0.136 
ISM2050 0.140 0.156 0.143 
Mab 0.479 
No Ag 0.044 
No Ab 0.032 
No conjugate 0.013 
135 
APPENDIX C: DEVELOPMENT OF A VACCINE TO MYCOPLASMA 
HYOPNEUMONIAE 
Introduction 
Mycoplasmal pneumonia of swine, as a result of Mycoplasma hyopneumoniae infection, 
is considered to be one of the most economically important causes of disease-associated loss in 
swine. Although M. hyopneumoniae infections rarely result in mortality, depressed growth 
rate, depressed feed consumption, and predisposition to secondary infection can result. Efforts 
to combat this disease have not proven to be entirely effective. Antibiotics have been shown to 
improve mycoplasma pneumonia; however, they do prevent the establishment of infection and 
subsequent lesions. Live, attenuated, bacterin, subunit, and M. hyopneumoniae supernatant 
vaccines have been tested, but have met with limited success. 
The goal of this study was to employ a recombinant DNA approach to construct an 
effective vaccine to M. hyopneumoniae. Monoclonal antibodies (Mab) have been produced in 
the laboratory of Dr. R. Ross to a 65-kDa major surface antigen of M. hyopneumoniae. These 
Mabs inhibit hemagglutination by M. hyopneumoniae. Therefore, the approach was to locate 
the gene encoding this 65 kDa protein by screening a M. hyopneumoniae genomic library with 
these Mabs. Once the gene was mapped by restriction analysis, it would be placed into an 
expression vector and transformed into a vaccine strain of Salmonella. The recombinant 
Salmonella vaccine strain would be given orally to swine to induce a mucosal immune response 
to M. hyopneumoniae. It was hoped that the recombinant approach would enhance the immune 
response to mycoplasma antigens on mucosal surfaces and thus provide protection. 
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Materials and Methods 
Preparation of the M. hyopneumoniae genomic library 
M. hyopneumoniae chromosomal DNA was partially digested with SauiAl and separated 
by size via sucrose density gradient centrifugation. Fractions possessing 9- to 22-kb fragments 
were pooled and ligated into XFIX cloning vector according to manufacturer's (Stratagene) 
instructions. Once the inserts were ligated into XFEX and packaged in vitro, the recombinant 
phage was plated on E. coli strain Q359, a P2 lysogen. The spi(-) selection prevented the 
growth of nonrecombinant phage. Approximately 1,200 independent recombinant phage were 
obtained and amplified in E. coli strain JM105. 
Monoclonal antibody production 
Two hybridoma cell lines producing Mabs to the 65-kDa protein of M. hyopneumoniae 
were a gift from Dr. R. Ross. The lines designated 80.1 and 27.10 were grown in RPMI 
medium containing 15% fetal bovine serum. Ten million cells were injected into pristane-
primed mice and ascites fluid was collected 4 to 7 days later. The antibody-containing ascites 
fluid was aliquoted and stored at -70°C. 
Screening of the M. hyopneumoniae genomic libraries 
One hundred microliters of 4 x 10^ pfu/ml were mixed with 100 |il of approximately 10^0 
JM105 cells/ml. After 15 to 20 min incubation at 37°C, the mixture was placed into 3 ml of soft 
agar and poured onto phage agar plates. Following incubation for 16 h at 37°C, the plaques 
were transferred to nitrocellulose filters. The filters were blocked with 3% BSA in Tris-saline 
for 30 min and then incubated for 1.5 h at room temperature with a 1:100 or 1:1,000 dilution of 
ascites fluid (80.1 or 27.10). The filters were washed (Tris-saline, 10 min; Tris-saline w/ 
0.05% NP-40, 15 min, 2 times; Tris-saline, 10 min). The second antibody, ^^^I-labeled goat 
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anti-mouse immunoglobulin was added for I h at room temperature. The filters were washed 
as previously described, dried, and exposed to film. 
Immunoblot blot analysis 
Approximately 50 |lg of E. coli %I91S, M. hyopneumoniae, and recombinants clones in 
E. coli lysates were loaded onto 10% SDS polyacrylamide gels. Following electrophoresis, the 
protein was transferred to nitrocellulose with a Hoeffer electroblotting transfer unit. Antigen 
detection on nitrocellulose was the same as the procedure used to screen the libraries. 
Results and Discussion 
Construction of the M. hyopneumoniae genomic library 
Ten- to twenty-kilobase M. hyopneumoniae DNA fragments were ligated into A,FIX, 
packaged in vitro, and plated on E. coli Q359. Approximately 1,200 independent recombinant 
phage were obtained. Because of the small size of the M. hyopneumoniae genome (ca. 800 
kb), it was determined that only 300 independent recombinant phage containing 15-kb inserts 
would be required to obtain a complete genomic library at the 99% confidence level. Thus, the 
1,200 independent clones in this library should represent the entire genome. 
Monoclonal antibody characterization 
The Mabs 80.1 and 27.10 both recognize a 65-kDa band when M. hyopneumoniae whole 
cell lysates are used in immunoblot analysis. The 80.1 Mab appeared to bind with greater 
affinity than did the 27.10 Mab. ELIS A analysis showed that the 80.1 Mab was over 10 times 
more effective in recognizing whole cells than the 27.10 Mab. As a result, the 80.1 Mab was 
used to screen die M. hyopneumoniae genomic library. 
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Screening the M. hyopneumoniae genomic library 
The phage library was plated on JM105 at a density of 500 plaques per plate and screened 
with Mab 80.1 at a dilution of 1:100. Initially there was high background, but it was eliminated 
by using the Mab 80.1 at a dilution of 1:1,000. Potentially positive clones were picked and 
stored at 4°C. Three microliters of the positive phage lysate was spotted onto soft agar 
containing JM105 cells and screened with both Mabs 80.1 and 27.10. Differing amounts of the 
ascites fluid of each Mab (1; 1,000 for 80.1 and 1:50 for 27.10) were required to obtain a 
positive reaction, however. Eleven of the potentially positive clones continued to be positive 
upon rescreening. 
Two of the positive clones were used by immunoblot analysis. The Mab 80.1 recognized a 
39.5-kDa protein, but the Mab 27.10 failed to recognize any protein using this approach. The 
observation that Mab 27.10 weakly recognized the same positive plaques as Mab 80.1, but did 
not recognize the 39.5-kDa recombinant protein upon immunoblot analysis may indicate that 
this epitope is not very stable in E. coli. Thus, the epitope recognized by this Mab may have 
been lost during the immunoblot analysis procedure. It should be noted that the Mab 27.10 
binds strongly to the 65-kDa antigen in immunoblot analysis of mycoplasmal whole cells. 
The observation that the Mab 80.1 recognized a 39.5-kDa band indicated that either the 
protein was expressed in a truncated form in E. coli or only part of the gene was cloned. 
Expression of truncated gene products in E. coli is a possibility because of the alternate codon 
usage between E. coli and mycoplasmas. Mycoplasmas use the UGA codon for a tryptophan 
while it is a stop codon in E. coli. Thus, mycoplasma proteins containing a tryptophan encoded 
by a UGA would be prematurely truncated in E. coli during translation. 
The truncation of the 65-kDa protein in E. coli may also be a result of improper post-
translational modification such as the linkage of the protein antigen to a lipid component. A 
protein of identical molecular weight was characterized as a lipoprotein in M. hyopneumoniae 
by another laboratory (K S. Wise, Univ. of Missouri). 
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APPENDIX D. DEVELOPMENT OF A RECOMBINANT VACCINE TO 
SERPVLINA HYODYSENTERIAE 
Description and Rationale 
The etiologic agent of swine dysentery, Serpulina hyodysenteriae (formerly Treponema 
hyodysenteriae), causes a mucohemorrhagic diarrhea in swine. Although the disease has been 
recognized since 1921, the mechanism(s) of pathogenesis of this disease has not been 
determined. The endotoxin and hemolysin, however, have been implicated as major virulence 
factors. The goal of the project, therefore, was to produce an effective vaccine to S. 
hyodysenteriae based on inducing an immune response to the lipopolysaccharide 0 antigen. 
This would be accomplished by using a recombinant DNA approach in which the genes 
producing the S. hyodysenteriae G antigen would be cloned and expressed using an alternative 
vaccine delivery system developed in Salmonella spp. Previous work in the laboratory of Dr. 
Wannemuehler with murine and porcine challenge studies showed that the antibody response in 
both convalescent and immunized animals appeared to be against the serotype antigen. In 
addition, it was shown that mice could be protected from S. hyodysenteriae infection by using 
an a monoclonal antibody to the S. hyodysenteriae LPS. Unfortunately, there are at least seven 
S. hyodysenteriae serotypes. Thus, the possibility of using a multivalent approach was 
considered. 
Initial experiments in the laboratory of Dr. Roy Curtiss HI (Washington University, St. 
Louis) indicated that they had developed an avirulent Salmonella vaccine delivery system for 
swine. The Salmonella could colonize in the intestine of the pig for at least ten days without 
producing any obvious signs of disease. Moreover, a significant antibody response was 
detected one week after challenge. 
Thus, in order to develop an effective vaccine against S. hyodysenteriae, the following 
approach was taken. First, the gene(s) encoding the S. hyodysenteriae LPS 0 antigen would 
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be cloned into Escherichia coli. Contiguous and noncontiguous S. hyodysenteriae genomic 
libraries were constructed in X.ZAP or in cosmid pISM24. A contiguous library consisted of 
large genomic inserts while the noncontiguous library was composed of small randomly 
associated genomic DNA fragments. The noncontiguous approach was taken because it has 
been shown that the LPS genes for other bacteria are located at a number of sites in the 
genome. Therefore, it was hoped that the noncontiguous library could generate a cassette in 
which the 5. hyodysenteriae LPS would be produced. The libraries were screened with 
hyperimmune rabbit antisera or a monoclonal antibody to the LPS of S. hyodysenteriae. 
Second, once a positive clone was detected the genes related to the O antigen would be 
mapped. The O antigen coding sequence would then be cloned into the Salmonella expression 
vector, pYA804. Third, the recombinant Salmonella would be tested to determine whether an O 
antigen-specific immune response could be induced in mice and swine. And fourth, the vaccine 
would be tested to determine whether oral immunization could give protection against S. 
hyodysenteriae. 
Materials and Methods 
Preparation of S. hyodysenteriae chromosoma! DNA 
Two liters of 5. hyodysenteriae B78 grown in a modified trypticase soy broth were 
washed once with PBS and resuspended in 1/200th of the original volume in NET buffer 
(0.1 M Tris, 0.15M NaCl, and 0.08M EDTA, pH 7.5). Lysozyme was added to a final 
concentration of 100 mg/ml and incubated for 2 h at 37°C. Proteinase K (100 mg/ml) was then 
added and incubated at 65°C for an additional 2 h. The cells were then lysed with a lysis buffer 
(1% Triton X-100,1% NP-40, and 1% deoxycholate) and proteinase K was immediately 
added and the lysate was incubate at 65°C for 2 h. The DNA was extracted with phenol and 
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phenol-chloroform, ethanol-precipitated and dialyzed against TE. Some of the DNA 
preparation was placed on a CsCl gradient for further purification. 
The chromosomal DNA was partially digested with SauSAl and the fragments were 
separated over a sucrose density gradient. The fragments were pooled into 1- to 5-kb, 5- to 10-
kb, 10- to 20-kb, and 20- to 50-kb pools for use in the appropriate cloning vector. 
Preparation of S. hyodysenteriae genomic libraries 
Preparation of genomic libraries In lambda. The S. hyodysenteriae libraries 
were constructed in the lambda vectors XZAP (Stratagene) and XGEM-11 (Promega) according 
to manufacturer's instructions. To prepare the genomic library in XZAP, 5- to 10-kb fragments 
were ligated into the BamYïl site, packaged using Gigapack (Stratagene), and allowed to infect 
E. coli BB4 or XL 1-blue cells. The library was amplified one time. To prepare the genomic 
library in A,GEM-11, 10- to 20-kb fragments were partially filled in with Klenow and ligated 
into the Xhol site, packaged using Packagene, and used to infect E. coli LE392 cells. 
Preparation of genomic libraries in cosmid pISM24. The 20- to 50-kb 
fragments were ligated into the unique BamiH site of cosmid pISM24 to generate the 
contiguous genomic library. The noncontiguous library was generated by using the 5- to 10-kb 
fragments. The ligation mixes were packaged using Gigapack and used to infect E. coli strains 
HBlOl, BB4, LE392, and XL 1-blue. The colonies were picked and grown up in 200 |il 
volumes in a 96-well plate. One half of the culture was placed in 40% glycerol and stored at 
-20°C and to other half of the culture was placed in 15% glycerol and stored at -70°C in 96-well 
plates. Forty-eight or 96-pin replicators were used to inoculate plates for subsequent screening. 
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Screening the S. hyodysenteriae genomic libraries 
The genomic libraries were screened with either pooled rabbit antisera to S. 
hyodysenteriae B78 whole cells or a monoclonal antibody (B78.18.2) to the S. hyodysenteriae 
B78 O antigen. Lambda libraries were screened from plaque lifts from plates containing about 
1000 plaques. The membranes were blocked overnight with TSB (0.05M Tris, 0.15 M NaCl, 
and 3% BSA, pH 7.5) at either 4°C, room temperature, or 37°C. Rabbit hyperimmune antisera 
that was diluted 1:250 in TSB and absorbed with lysed E. coli cells was added to the filters and 
gently shaken for 2 h at room temperature. The filters were washed (1 time with TS, 10 min; 2 
times with TSN (TS with 0.05% NP-40), 20 min; and 1 time with TS, 10 min) then secondary 
antibody (^^^I-Protein G, approx. 10^ cpm/ml) diluted in TSB was added and incubated at 
room temperature for 2 h. Autoradiography was used to detect reactive plaques. 
The cosmid libraries were screened by first inoculating LB containing 100 |Lig/ml 
ampicillin with a 48-pin replicator from the 96-well plate stocks. Colony lifts were performed 
and the cells were either lysed with chloroform and placed in TSB containing 100 |ig/ml 
lysozyme and 1 |ig/ml DNase or were not lysed at all. The rest of the screening protocol was 
the same as above. 
Results and Discussion 
Construction of 5. hyodysenteriae genomic libraries 
Two XZAP libraries were constructed from 2 different ligation mixes. It was predicted that 
I,500 to 3,000 independent plaques would be necessary to be 99% confident that the entire 
genome (estimated to be 3,300 kb) would be cloned using 5- to 10-kb inserts. The 8,000 and 
II,000 independent clones obtained with the two libraries should be sufficient to contain the 
entire S. hyodysenteriae genome. Scoring for the blue/white phenotype on plates containing X-
gal and IPTG showed that less than 1% of the plaques were blue indicating that most of the 
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clones possessed insert DNA. Fifteen plaques from each library were picked and DNA was 
prepared. Restriction enzyme analysis showed that 15 of 15 clones in one library and 14 of 15 
clones in the other library appeared to possess inserts. Each library was amplified one time to 
give libraries with titers of 1 x 10^ and 1.4 x 10* pfu/ml. No plaques were generated using the 
XGEM-11 vector probably due to the inability to effectively partially fill-in the insert DNA prior 
to ligation with the XGEM-11 vector. Thus, only the AZAP library was used to screen for the 
O antigen gene(s). 
The cosmid libraries were generated by ligating S. hyodysenteriae genomic fragments into 
the cosmid pISM24. Cosmid pISM24 is a derivative of cosmid pJB8 in which the multiple 
cloning site from pBluescript was inserted into the EcoRI site of pJB8. The contiguous library 
was constructed with inserts that were greater than 20-kb whereas the noncontiguous library 
was constructed with 5-to 10-kb fragments. Eight colonies from each library were picked and 
plasmids were prepared. Restriction enzyme analysis showed that the library was composed of 
large inserts of ca. 40-kb and the differing restriction patterns indicated that the inserts were 
different. DNA-DNA hybridization analysis using S. hyodysenteriae genomic DNA as a probe 
showed that the insert DNA was S. hyodysenteriae. These results indicated that a S. 
hyodysenteriae genomic library had been constructed using cosmid pISM24. Therefore, 
approximately 1,750 contiguous and 2,600 noncontiguous independent recombinant clones 
were picked and stored in 96-well plates for future analysis. 
Screening the S. hyodysenteriae libraries generated using XZAP 
The amplified S. hyodysenteriae libraries were initially screened with rabbit hyperimmune 
antisera. High background was encountered in the initial attempts. The high background was 
alleviated by first absorbing both the primary and secondary antibodies with lysed E. coli 
HBlOl cells prior to the screening procedure. The positive control in these experiments was 
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lysed S. hyodysenteriae B78 cells and the negative control was lysed E. coli HBlOl cells. No 
positive clones were generated but both the positive and negative controls reacted as predicted. 
The screening of these libraries was repeated with the monoclonal B78.18.2 as the primary 
antibody. Again, no positive clones were detected despite both controls working as expected. 
It would have been predicted that some positive clones would have been detected if S. 
hyodysenteriae genes were being expressed. The amplified library was rechecked and the 
clones did not appear to have inserts. Therefore, the inability to detect positive clones at this 
point was due to the lack of recombinants containing S. hyodysenteriae DNA. 
The packaging mixes were then reexamined to ensure that 5. hyodysenteriae DNA 
fragments were indeed inserted into A,ZAP. Restriction enzyme analysis as well as DNA-DNA 
hybridization analysis using 5. hyodysenteriae genomic DNA as a probe confirmed previous 
observations that the unamplified library contained in the packaging mix had S. hyodysenteriae 
inserts. The probe did not bind to the XZAP DNA negative control or to the bands that 
corresponded to the vector in the recombinant lanes. The unamplified library was then screened 
with both the rabbit hyperimmune antisera and the monoclonal antibody B78.18.2. Again, no 
positive clones were detected and the controls worked as expected. 
The inability to detect positive clones, especially with the rabbit hyperimmune antisera, is 
difficult to explain. One possibility is that the gene products were lethal to the E. coli cell. This 
is unlikely because it could be reasoned that some S. hyodysenteriae gene products would be 
stably maintained and expressed in E. coli, yet the antisera failed to detect anything. 
Screening the 5. hyodysenteriae libraries generated using pISM24 
Because efforts to detect the S. hyodysenteriae O antigen were unsuccessful using lambda 
vectors, cosmid vectors were examined. In E. coli, multiple genes from different regions of the 
genome are required for the expression of the O antigen. Thus, it was predicted that the genes 
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required for the expression of the S. hyodysenteriae LPS would be similarly spread around the 
genome. 
One of the reasons for trying to express the O antigen in E. coli K-12 is that E. coli K-12 
does not express the O antigen in its LPS. Thus, it was hoped that the gene product in the 
cosmid clones would complement the O antigen mutation and permit expression on the surface 
of the E. coli cell. This was demonstrated previously with Neisseria gonorrhoeae in that the O 
antigen from N. gonorrhoeae was expressed on the surface of HBIOI. 
Therefore, one screening approach was to determine whether the S. hyodysenteriae O 
antigen was being expressed on the surface of the E. coli HBlOl by using unlysed cells. 
Twenty-six potentially positive clones were detected with both the rabbit hyperimmune rabbit 
antisera and the monoclonal antibody. The positive reactions were weak, however. None of the 
26 clones continued to give a positive reaction upon reexamination. Immunoblot analysis was 
tried in an attempt to increase the amount of the gene product so it could be detected by the 
antisera. In addition, ten of the potentially positive clones were treated with Proteinase K prior 
to the lysis step to try to enhance the detection process and to examine whether Proteinase K 
treatment alters the antigen recognized by the antisera to S. hyodysenteriae. All attempts to 
detect the O antigen by immunoblot analysis were unsuccessful. ELIS A analysis was also 
performed and no positive reaction was detected. It should be noted that in the colony lifts, 
immunoblot analyses, and ELIS A analyses that both the positive (lysed S. hyodysenteriae 
cells) and negative (lysed HBlOl cells) controls worked as expected. 
To determine why these clones were no longer reacting positively with the antisera, DNA 
was prepared by the Triton lysis procedure. Restriction enzyme analysis of these clones 
showed that most of the inserts were now less than 12-kb. DNA-DNA hybridization analysis 
with S. hyodysenteriae genomic DNA confirmed that about 10-kb of each clone continued to 
be present. Apparently the inserts in these cosmids were very unstable. 
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It should be noted that the cosmids could only be grown in HBlOl and not in BB4, XLl-
blue, or LE392 E. coli cells. This suggested a possible restriction/modification barrier to the 
cloned inserts. None of the clones from the contiguous library gave a positive reaction with 
either the hyperimmune rabbit andsera or the monoclonal antibody. A total of 17 attempts were 
made to locate positive clone from both the contiguous and noncontiguous genomic libraries. 
In summary, the attempts to clone the gene(s) responsible for S. hyodysenteriae O antigen 
production were unsuccessful. Apparently, the cosmid clones were very unstable because after 
several rounds of amplification and growth the insert size was greatly reduced. Instability of 
cosmid inserts has been noted in other systems. As an effort to reduce cosmid instability the 
possibility of using a low copy number cosmid, pPR691, was considered. The inability to 
detect any S. hyodysenteriae gene products in E. coli with the rabbit hyperimmune antisera 
despite confirmation of cloned inserts remains an enigma. Perhaps the S. hyodysenteriae gene 
regulatory regions (i. e., promoters and translation initiation regions) are not recognized in E. 
coli. 
